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ABSTRACT 
Xianai Wu, Patricia Murphy, Joan Cunnick and Suzanne Hendrich 
Deoxynivalenol (DON) is a mycotoxin commonly contaminating corn, wheat and barley. 
DON glucuronide (DONGLU) was synthesized with rat liver microsomes, uridine-5' - 
dephosphoglucuronic acid (UDPGA) and DON. DONGLU was purified with a Sephadex 
LH-20 column and HPLC (revere phase column, UV at 220 nm). ~i- glucuronidase hydrolysis 
formed a product with retention time and UV spectrum identical with DON. HPLC 
chromatography of DONGLU reaction mix with/without UDPGA or with/without 
microsomes showed that only in the complete reaction mix was there a peak more 
hydrophilic than_ DON but with similar UV spectrum, putatively DONGLU. DONGLU was 
further identified by mass spectrometry in negative ionization mode and NMR. The 
molecular mass (M-1) was 471 g/mol, in agreement with DONGLU's expected molecular 
weight of 472 g/mol. ~3- glucuronidase hydrolysis, MS and NMR indicated that the 
glucuronide moiety was conjugated with the carbon- 3 hydroxyl group of DON. The 
cytotoxicity of DON ~ and DONGLU were compared in cell culture using human 
erythroleukemia cell line K562. 50% inhibition of cell proliferation was observed with a 
DON concentration of 1.31 µM using CellTitre96TM detection, whereas no significant 
cytotoxicity was observed for DONGLU at up to 270µM. DONGLU did not influence DON 
toxicity at low, medium and high concentration combinations (0.5 µM, 1.3 µM and 8.4 µM) 
of each compound. These data show that DONGLU is a detoxification product of DON, and 
that measuring DON without DONGLU in human urine or plasma would be a suitable 
biomarker of DON exposure and toxicity. 
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INTRODUCTION 
Deoxynivalenol (DON) is a trichothecene mycotoxin produced by Fusa~ium fungi, 
specifically F. g~aminea~ufn and F. culjno~um, which are common contaminants of various 
cereal crops such as wheat, maize, barley, and oats. The formation of DON in growing 
crops is dependent on :climate and will thus vary between geographical regions. Moreover, 
DON can also be produced during storage when moisture content of stored grains is less 
rigorously controlled (Lombaert et al. 2003; Lori et al. 2003; review by wHO, 1990 and 
Pacin et al. 1997). A survey done in 1993 of DON in U.S. showed DON contamination in 
wheat samples averaging 2.0 µg/g and ranging from < 0.5 to 18 µg/g. DON contamination 
in barley samples averaged 4.2 µg/g and ranged from < 0.5 to 26 µg/g.. About 40% of the 
wheat samples and 57% of the barley samples contained DON levels that were greater than 
the U.S. Food and Drug Administration 1982 advisory level of 2µg/g for DON in wheat 
designated for milling (human consumption) (Trucksess et al. 1995). DON exposure 
investigated in Canada in 2003 found that DON was the most frequently detected 
mycotoxin and detected in 63 % sample analyzed in cereal based infant food (Lombaert et 
al. 2003). 
DON exposure possibly inhibits immune system function through suppressing 
lymphocyte proliferation and decreasing non-specific host defenses resulting in an 
increased susceptibility for infectious diseases. In vitro exposure of human lymphocytes to 
DON showed that DON inhibited mitogen-induced lymphocyte proliferation with ICSo 216 
ng/ml (Thuvander et al. 1999). Exposure to DON induces immature and mature B cells 
apoptosis and cytotoxicity after exposure at 100-1000 ng/ml for 18 h, with ECSo at 500 
ng/ml for apoptosis and 300 ng/ml for cytotoxicity, respectively (Uzarski et al. 2003). DON 
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exposure exerted an inhibitory effect on resident macrophages and natural killer (NK) cells. 
Mouse peritoneal macrophages pre-incubated with 1 ng DON/mL for 4 h showed inhibited 
phagocytosis and microbicidal killing against a model microbial, opsonized Saccha~o~nyces 
cerevisiae (Ayral et al., 1992). By investigating antibody-dependent cellular cytotoxicity 
and natural killer (NK) cell activity, Berek et al. (2001) observed DON inhibited NK cells 
activity at 50 ng/ml. Male Balb/c mice (4~6 weeks of age) were fed DON daily for 1 or 2 
weeks at doses of 2.5 to 100 ppm in the diet. Liver and kidney weights were not changed 
whereas thymus weight was reduced significantly at concentration > 10 ppm (Robbana- 
Barnat et al., 1988). These results suggest leukocytes and the immune system are primary 
targets for DON. 
DON is found in foods such as corn, wheat and barley. Processing, milling and baking 
showed little reduction in DON levels (Castells et al. 2005). After consuming DON 
contaminated food, DON was quickly absorbed in the stomach and the proximal small 
intestine in swine (Danicke et al. 2004). Following administration of a single oral 10 mg/kg 
dose in male PVG rats, radioactivity excreted in the urine and feces accounted, respectively, 
for 25 and 64% of the administered dose within 96 h (Lake et al. 1987). After oral 
administration the major metabolic routes are de-epoxidation to DOM-1 due to gut 
microbes and glucuronide conjugation due to biotransformation by UDP-glucuronosyl- 
transferases. DOM-1 has been found in urine of rats and in urine and plasma of cow 
(Worrell et al., 1989; Cote et al., 1986). De-epoxidation is a detoxification reaction. In 
vitro, DOM-1 was 55 times less toxic than DON in Swiss mouse 3T3 fibroblasts (3T3 cells) 
(Sundstol Eriksen et al., 2004). The biological activity of DON glucuronide has not been 
reported yet. We hypothesized that DON glucuronide is a detoxification product of DON 
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that does not interact with DON toxicity. Meky et al. (2002) found that DON glucuronide is 
present in human urine. After treating human urine with (3-glucuronidase, the increase in 
DON ranged from 1.2-2.8 fold. Generally, biotransformation serves to enhance parent 
compound detoxification and elimination. Zhang et al. (1999) found that isoflavone 
glucuronide was much less immunotoxic to natural killer cells in vitro than the parent 
compounds. However, in some cases, after conjugation, the biological activities of the 
conjugates were enhanced. For example, Ghaoui et al. (2003) demonstrated that clofibric 
acid undergoes glucuronidation-dependent bioactivation to DNA damaging species in 
cultured mouse hepatocytes. The formation of aromatic amine glucuronides causes bladder 
cancer (Thorgeirsson et al.. 1983). Therefore, the current study is to synthesize and purify 
DON glucuronide to compare immunotoxicity of DON glucuronide and DON in an in vitNo 
model. Human K562 erythroleukemia cell line was used in our research to compare 
immunotoxicity of DON and its glucuronide. K562 cells were selected as a model because 
they are very early erythroid precursors and like lymphoblasts in morphology (Koeffler and 
Golde 1980). At the same time, K562 ~ cells are easily grown in vitro without mitogen, so 
they may be a convenient model of human lymphocyte precursors. 
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LITERATURE REVIEW 
General information 
Deoxynivalenol (DON, vomitoxin) is a type B trichothecene. About 150 related 
compounds are known as trichothecenes, which are formed by a numbers of species of 
Fusa~ium and some other fungi. The occurrence of DON is associated primarily with 
Fusa~ium g~anZinea~unZ (Gibbe~ella zeae) and F. culjno~unZ, both of which are important 
plant pathogens which cause Fusa~iuYn head blight in wheat and Gibbe~ella ear rot in 
maize. F. g~ajninea~um grows optimally at a temperature of 25 °C and at a water activity 
above 0.88. F. culyno~um grows optimally at 21 °C and at a water activity above 0.87. The 
formation of DON in ;growing crops is dependent on climate and will thus vary between 
geographical regions. Moreover, DON can also be produced during storage where moisture 
content of stored grains is less rigorously controlled (Christian Larsen et al., 2004; review 
by WHO, 1990; Isebaert et al., 2004; Lori et al., 2003). 
DON is one of the more polar trichothecenes with molecular weight, 296.3 g mol"1 and 
the molecular formula C 15H2O0 6. It has a 12, 13 epoxy group, OH group, and an a, ~3-
unsaturated keto group, with the chemical name is 12, 13 -epoxy-3 a, 7a, 15 -trihydroxy- 
trichothec-9-en-8-one (Fig 1). It is soluble in water and polar solvents such as methanol and 
acetonitrile. DON has a maximum absorption at 218nm. For UV-determination and 
spectrophotometric determination; acetonitrile is a better solvent than methanol. DON is 
heat stable at 120°C and is not decomposed under mildly acidic conditions (Krska et al., 
2001). 
DON occurs predominantly in grains such as wheat, barley, oats, rye, and maize, and 
less often in rice, sorghum, and triticale. Because it is a stable compound it has also been 
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detected in a range of processed cereal products including breakfast cereals, bread, noodles, 
infant foods, malt and beer. Concentrations have been reported at up to 26 mg/kg in barley 
and 18 mg/kg in wheat (Trucksess et al. 1995, 1996; Lombaert et al. 2003; MacDonald et 
al. 2004; Castells et al. 2005). 
The cause of head blight (scab) of wheat and barley has emerged as the plant disease 
with the greatest impact on U.S. agriculture and society during the past decade. Scab has 
occurred frequently in the Midwest because of recurrent cool rainy weather during wheat 
and barley flowering (McMullen et al.., 1997; Windels, 2000). In contaminated cereals 3 - 
and 1 S-acetyl DON can co-occur in significant amounts with DON. 3 -acetyl DON is 
prevalent in Europe; 15-acetyl DON is prevalent in North America. These toxins are often 
present at the levels of 10-20% that of DON (Christian Larsen et al., 2004). It is possible 
that these toxins can be degraded to DON due to microbial in the alimentary tracts of 
ruminants and non-ruminants (Binder et al. 1998; Eriksen et al. 2003). 
Austria, Canada, US and the European Union (EU) have guideline limits for DON. US 
Food and Drug Administration voluntary advisory levels for DON stipulate no more than 1 
mg/kg for bran, flour, and germ for human consumption (FDA/CFSAN, Chapter 7). Several 
European guidelines recommend maximum levels of DON of 500 ng/g for cereal products 
as consumed and 750 ng/g for flour used as raw materials in food products and raw cereals 
(Codex Alimentarius Commission FAO/WHO, 2003). 
Detoxification strategies 
DON is thermally stable so it is difficult to eliminate from grain once formed. Because 
DON is water-soluble a significant proportion can be removed by washing grain but 
commercially this represents an additional stage and an effluent problem. Other 
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detoxification strategies include enzyme reactions, food processing or other alternative 
methods. 
0 
OH 
Fig 1: The chemical structure of DON (MW=296) 
Biological detoxification strategies include the use of exogenous enzymes or bacteria 
to hydrolyze the 12-13 epoxide ring, which is responsible for the toxicological properties of 
DON. It is determined that de-epoxy DON has 55 times less toxicity than DON in Swiss 
mouse 3T3 fibroblasts; (Sundstol Eriksen et al. 2004). For example, the incubation of DON- 
contaminated corn with the cecal microflora from chickens reduced the anorectic potential 
of the corn and improved the performance of swine. He et al. (1992) found that 
microorganisms in large intestines of chickens (MLIC) completely transformed pure DON. 
A single metabolite was isolated and identified as de-epoxy DON, DOM-1 (Fig 2). The 
DON transformation rate was not affected by either the ratio of MLIC to DON (5 to 0.2 g of 
MLIC per mg of DON) or the initial concentration of DON (14 to 1,400 ppm) in the 
medium. Sodium azide at a 0.1 % (wt/vol) concentration in the medium blocked the 
transformation of DON, indicating that the de-epoxidation of DON is energy dependent and 
microbial. However, DON in the moldy corn was not transformed when MLIC were added 
to corn without culture medium. Biotransformation of DON was completely inhibited when 
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the pH in the medium was lowered to 5.2. After incubation of MLIC and moldy corn, 
approximately 79 and 47% of the initial DON were recovery after 48 and 96 h of 
incubation. However, . the pH in the ~ medium decreased from 6.5 to 3.5 in the 96 h 
incubation period, presumably because of organic acids produced during corn fermentation. 
At the same time, the buffer failed to neutralize the acid produced from corn fermentation. 
These results indicate that control of the pH in the incubation medium is critical for further 
transformation. As a result, incubation of MLIC and moldy corn for 96 h can partial 
biotransform DON to de-epoxy-DON. Depending on the concentration of DON, this moldy 
corn could be used feed animals such as cows and sheep. 
DON can also be transformed to DOM-1 by microorganisms in rumen fluid and soil. 
Binder et al. (1998) found DON and 3-acetyl DON were transformed by ruminal 
microorganisms to a single metabolite, which was identified by GC-MS as DOM-1 . DOM-
1 from either trichothecene showed a significant reduction in toxicity against 
Saccha~omyces ce~evisiae. Aerobic biotransformation of DON and 3 -acetyl DON by 
microorganisms in soil, respectively, gave five new metabolites as indicated by HPLC and 
TLC determination. These five new metabolites were unknown. 3 -acetyl DON was de- 
acetylated to DON within 24h; the following reactions also produced five new metabolites 
by soil microorganisms just like DON as original mycotoxin. The toxicity of these 
metabolites against S . ce~evisiae was reduced. 
DON can be transformed to 3-keto-4-deoxynivalenol by some bacteria in soil (Fig 3). 
A soil bacteria, strain E3 -3 9, Agrobacterium-Rhizobium group, was isolated by Shima et al. 
(1997). This bacterium completely eliminated exogenously supplied DON from culture 
medium after incubation for 1 day. Thin-layer chromatographic analysis indicated the 
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presence of one major and two minor metabolites of DON in ethyl acetate extracts of the 
E3-39 culture filtrates. The main metabolite was identified as 3-keto-4-deoxynivalenol by 
mass spectroscopy and 1H and 13C nuclear magnetic resonance analysis. This compound 
e~iibited a remarkably decreased (to less than one tenth) immunosuppressive effect 
evaluated by means of a bioassay based on the mitogen-induced and mitogen-free 
proliferations of mouse spleen lymphocytes. 
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Fig 2: The chemical structure of de-epoxy-deoxynivalenol (DOM-1) 
Under aerobic conditions, Volkl et al. (2004) found that DON was biotransformed to 
3-keto-4-deoxynivalenol by a microorganism after screening 1285 microbial cultures from 
farmland soil, cereal grains, insects and other sources. DON was isolated both from ears 
that were visibly infected with Fusa~ium and from symptomless grain grown on test fields. 
One mixed culture transformed DON into two chromatographically separable products. The 
main product of the transformation was purified and its structure was elucidated by mass 
spectroscopy, and NMR spectroscopy. The structure of this product was determined to be 
3 -keto-4-deoxynivalenol. The DON-transforming mixed culture survived and retained its 
transforming activity during a starvation period of six months at 20° C. Transformation of 
DON was suppressed by low concentrations of glucose and high concentrations of tryptone 
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and yeast extract. Trichothecenes 15-acetyl DON, 3-acetyl DON and fusarenon-X were also 
transformed. 
16 
HNC 
O 
Fig 3 : The chemical structure of 3 -keto-4-deoxynivalenol 
Alternative approaches for the removal of DON from grains include the use of 
washing or soaking procedures and physical methods, such as dehulling. With respect to the 
latter, House et al. (2003) researched the efficiency of DON removal from barley samples 
through. the use of an ;abrasive pearling procedure at varying levels of contamination. The 
results showed that pearling was an effective means of reducing the DON content of barley, 
with improvements in nutrient levels of barley because DON could affect nutrient 
absorption in the intestine through modulating the activities of intestinal transporters 
(Maresca et al., 2002). Following 15 s of pearling, the grain contained 34% of the initial 
DON content, irrespective of the initial level of contamination. However, the need to reduce 
the DON content of contaminated barley to less than 1 ppm for swine will necessitate the 
removal of a significant amount of the grain mass for heavily contaminated samples. 
Additional pearling resulted in a linear decline of grain mass. Further pearling resulted in 
continued significant (p < 0.05) reductions in the percent of DON remaining to a level of 
7.9% after 120 s but with significant losses in grain mass. 
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Many spices and: herbs and their extracts possess antimicrobial activity because of 
their essential oil fraction. Therefore, these essential oils could be use as alternatives to food 
preservatives currently in use. Velluti et al. (2004) investigated the efficacy of cinnamon, 
clove, lemongrass, palmarose and oregano oils on growth rate and DON production by F. 
graminearum in irradiated maize grain at different water activities and temperature 
conditions. The influence of the essential oils was tested on irradiated maize at two 
concentrations (500 and 1000 mg/kg), at different water activity (aw) (0.950 and 0.995) and 
temperature (20 and 30 °C) levels. At 0.995 aw, all essential oils tested had an inhibitory 
effect on growth rate of F. g~arninea~um at both temperatures studied. At this aw, DON 
production in general was significantly inhibited by all essential oils at 30°C compared to 
control. Therefore, essential oils should be considered as alternative post-harvest natural 
fungicides. These results also indicate that antifungal and antimycotoxigenic activity of the 
essential oils depended on environmental conditions. 
Detection methods 
DON can be extracted from cereals using aqueous solvent mixtures such as methanol 
and water or acetonitrile and water. Mechanical shaking or blending with aqueous 
acetonitrile (acetonitrile: water 84:16, v/v) usually results in extraction of the relatively 
polar DON. The main procedures employed for clean up in trichochecene analysis are 
liquid-liquid partitioning, solid-phase extraction (SPE), column chromatography, and use of 
immuno~nity column (IAC) and multifunctional clean-up columns. Liquid-liquid 
partitioning can be employed by shaking the sample extract with an immiscible solvent in a 
tube, such as ethyl acetate (Gareis et al., 1987). Column chromatography can be performed 
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on a variety of stationary phases. Sep-pak cartridge (C 18) has been successfully used to 
clean up DON in our laboratory. The most frequently employed column packing material 
for DON is a mixture of charcoal, alumina, and celite with ratio of alumina: celite: charcoal 
(0.35 + 0.25 + 0.4 g) (Omurtag and Beyoglu 2003) or alumina: charcoal: celite (7 + S + 3) 
(Fernandez, 1994). Use of an immunoaffinity column to extract DON was based on DON 
binding to DON-specific antibodies linked to an organic carrier material, and then DON 
could be eluted by use of pure organic solvents. Commercial multifunctional Mycosep® 
clean-up columns are available to clean several trichothecenes simultaneously. Combined 
HPLC and GC Mycosep® columns are frequently employed. 
Because DON has some UV absorbance, it is possible to detect it using TLC or HPLC 
with UV detection methods. C 1 s reversed phase columns with methanol-water mixture or 
acetonitrile-water mixture as mobile phase were used for HPLC. Recently, LC-MS 
instruments, particularly using APCI (atmospheric pressure chemical ionization) interfaces 
have recently been employed for the determination and identification of trichothecenes, 
including DON, at trace levels. GC-ECD (Electron Capture Detector) and GC-MS are 
available to detect DON with detection limit 20 ng/g. The advantage .of this is that other 
related compounds can be determined simultaneously with high sensitivity. The 
disadvantages are that DON is non-volatile and must be derivatized to form a stable 
compound suitable for analysis. Expensive equipment and skilled operators are required for 
GC-MS. ELISA assays and cell proliferation assays have been developed for quick and 
simple screening. The limit of ELISA is that it cannot distinguish between DON, 3-acetyl 
DON, 15-acetyl DON, and 3, 15, di-acetyl DON because the antibodies used are designed 
against 3, 7, 15-tri-acetyl DON (Krska et al. 2001). The elimination of cytotoxic matrix 
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substances is crucial when screening food samples for toxic substances using cell 
proliferation assays. Therefore, thorough purification of the sample is required. At the same 
time, the sensitivity of the cell line is critical when applying an in vitro cytotoxicity assay 
for screening of DON. As a result, the method of choice depends on the instrumentation 
available, the required detection limit, matrix composition and. the properties of the analyte. 
ELISA assay has the lowest detection limit with 0.2 ng/ml in buffer without clean up after 
extraction (Ngundi et al. 2006), however, ELISA has crossreactivity between DON and 
other trichothecenes (Krska et al. 2001). Immunoaffinity column enrichment and HPLC- 
MS/iJV detector has a very low detection limit at 12-20 ng/ml and can detect individual 
compounds specifically (Janes and Schuster 2001; Meky et al. 2003). The cheapest method 
is clean up using alumina and charcoal SPE column combined with cell proliferation assay. 
At the same time, it was reported that this method has a good correlation with an HPLC 
method (Landgren 2005). Table 1 shows the current methods to use for detection of DON in 
different matrices. 
Table 1: Quantitative and screening detection method for DON 
Detection method 
. 
Matrix 
Extraction, clean-up and special 
considerations 
Recovery and 
detection limit 
Reference 
TLC 
. 
gram 
Hazardous waste production, 
time consuming 
300 ng/g 
Scott 
(1995) 
GC 
Corn, milk, 
urine, feces 
acetonitrile: water (84:16), 
Mycochar column, and Cig
cartridge 
82%, 50 ng/g 
Cote et al. 
(1986) 
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Detection method Matrix 
Extraction, clean-up and special 
considerations 
Recovery and 
detection limit 
Reference 
HPLC-APCI-MS 
Polar-RP Cig column 
Pig urine, 
maize 
Extract using acetonitrile: water 
(84:16). Clean-up using 
MycoSep® column, 
simultaneous determination of 
B-trichothecenes and DOM-1. 
Dexamethasone as internal 
standard 
63.7-102.3 
25-150 ng/g 
Razzazi-
Fazeli et 
al. (2003) 
HPLC-UV (218 nm) 
Supelco®-Cig 
GC-ECD 
Cereal and 
flour 
Extract using water and 
polyethylene glycol. 
Immunoaffmrty column-HPLC 
MycoSep 225-GC/ECD 
80-96% 
20 ng/g 
Kotal and 
Radova 
(2002) 
LC-APCI-MS 
(23 0 nm) 
RP Cig Aquasil® 
column, 
100mmx 4.6mm, 
3µm 
Wheat 
Extract using acetonitrile: water 
(84:16). MycoSep column, 
Detect both of DON glucoside 
and DON. Silica gel normal 
phase MPLC(medium pressure) 
. 
and semipreparative reversed 
. 
phase HPLC (Jupiter Cig, 250 
mm x 15 mm i.d., 10 µM) used 
to purify DON glucoside. 
No information 
Berthiller 
et al. 
(2005) 
HPLC-MS 
Supelcosil® RP Cig
column. 25 cm x 4.6 
mm, 5µm 
Rat plasma, 
urine and 
Human 
urine 
Immunoaffinity column 
. 
enrichment 
First paper reported 
measurement of a urinary 
. 
biomarker for DON in human 
<12 ng/ml 
Meky et 
al. (2003) 
HPLC-UV 
Yolk and 
albumen of 
eggs 
Extract using acetonitrile: water 
and a mixture of charcoal, 
alumina and celite, and pass 
through an immunoaffinity 
column. 
Detected DON and DOM-1 
72-80% 
1-2.5 ng/g 
Valenta 
and 
, 
Danlcke 
(2005) 
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Detection method 
. 
Matrix 
Extraction, clean-up and special 
considerations 
Recovery and 
detection limit 
Reference 
HPLC-MS 
Aquasil® RP Cig
100 mm x 4.6 mm, 3 
µm 
Maize 
Multifunctional MycoSep 
column. 
Simultaneous detection of major 
trichothecenes 
0.3 -3.8 ng/g 
B erthiller 
et al. 
(2005) 
HPLC-UV (220 nm) 
. 
Llchrosorb® RP C18
5µm, 4 X 250mm 
Swine 
Blood, bile, 
Urine and 
excrement 
Fresh blood stirred 2h. Extract 
using acetonitrile-water (84:16) 
and clean up using 
immunoaffinity column. 
. , 
Additional purification step 
required for bile and extreta. 
75-90% 
0.01-0.02 µg/ml 
Janes and 
Schuster 
(2001) 
HPLC-UV Wheat 
Extract using acetonitrile: water 
(84:16), clean using alumina and 
charcoal SPE column. First use 
of caffeine as internal standard 
100.5% 
Landgren 
(2005) 
Enzyme linked 
immunosorbent 
assay 
GC-MS 
Cereals and 
foods 
Components derived from the 
wheat extract did not interfere 
with the ELISA kits. Rapid (<2 
h). Good correlation with GS- 
MS 
80 ng/g 
93.8-112% 
Yoshizaw 
a et al. 
(2004) 
ELISA 
Food 
. 
matrixes and 
indoor air 
samples 
Extracted with methanol-water 
(3 : l) and assayed without 
cleanup or preconcentration 
0.2 ng/mL in 
buffer to 50 ng/g 
in oats, air 
sampler was 4 
ng/mL 
. 
Ngundi et 
al. (2006) 
. 
Biassay 
3 T3 cells 
Wheat, 
wheat bran 
and barley 
Extract using acetonitrile: water 
(84:16). Multifunction MycoSep 
column. BrdU bioassay 
~37 ng/g 
Widestran 
d et al. 
(2003) 
Bioassay 
K562 cells 
Corn and 
wheat 
Extract using acetonitriie: water 
(84:16), alumina and charcoal 
SPE column. MTS assay 
140 ng/ml 
Landgren 
(2005) 
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Toxicokinetics and metabolism 
Absorption, distribution, and excretion 
(a) Gastrointestinal metabolism 
De-expoxidation of DON is a main metabolism of DON in alimentary tracts due to 
microorganism in the gastrointestinal tract. De-epoxidation is a detoxification reaction 
because the epoxide group seems to be essential for toxicity. Ruminants are less sensitive to 
the effects of trichothecenes, which may be due at least in part to differences in metabolism 
of trichothecenes by microorganisms present or difference in microbes in the alimentary 
tracts of ruminants and non-ruminants. DON was incubated in vitro for 12, 24 and 48 h 
with rumen microorganisms obtained from a fistulated dairy cow. Gas chromatographic and 
gas chromatographic-mass spectrometric analyses of extracts indicated DON was partially 
converted to a product identified as de-epoxy DON (DOM-1) under anaerobic condition 
(Swanson 1987). Similar results showing rumen fluid microbial degradation of DON to 
DOM-1 has been found in other studies under anaerobic conditions (He et al., 1992; Binder 
et al., 1998). Binder et al. (1997) tried to screen for DON detoxifying anaerobic nunen 
microorganisms. After several serial dilutions in optimized medium under anaerobic 
conditions the culture ; consists of two microorganisms. Both microorganisms were Gram- 
positive, the active biotransforming bacterium in this coculture was a nonspore-forming, 
strictly anaerobic irregular rod (0, 2 by 1-1.5 µm) occurring singly and in long chains up to 
150 µm. No growth occurred on solid media. Yeast extract and hemin were essential. 
Worrell et al. (1989) found gut microorganisms in male Sprague-Dawley rats that 
transformed DON to de-epoxy DON (DOM-1). Oral administration of 10 mg/kg of 14C-
16 
DON to rats resulted., in the appearance of a de-epoxy metabolite in urine and feces. 
Incubation of DON with a strictly anaerobic preparation of gut contents resulted in the 
progressive appearance of de-epoxy DON during a 24 h incubation period. Incubation of 
DON with rat liver homogenate did not result in the appearance of the de-epoxy DON 
metabolite. These results indicate that the presence of de-epoxy DON in rat excreta, 
following the oral administration of DON was the result of metabolism by microorganisms 
in the gut. Microbial degradation of DON in large intestine content of chickens and swine 
was investigated by He et al. (1992). ~ They found microorganisms in large intestines of 
chickens completely transformed pure DON. A single metabolite was isolated and 
identified as de-epoxy deoxynivalenol, DOM- l . However, no alteration of the toxin by 
incubation with microbes from the contents of the large intestines of swine was detected. 
However, Danicke et al. (2004) found gut microbes in pig had de-expoxidation activity, and 
de-epoxy DON appeared in increasing proportions from the distal small intestine and 
reached approximately 80% of the sum of DON plus de-epoxy-DON in feces collected 
from the rectum. Research by Eriksen et al. (2003) showed that no de-epoxy-DON was 
found in plasma or urine of pigs after trichothecene exposure, even in pigs having fecal 
microflora with de-epoxidation activity. It was concluded that de-epoxidation of DON, 
which primarily occurs in the hindgut, probably does not contribute to DON detoxification 
in the pig. 
It is unknown if DON can be transformed to DOM-1 by human gut microbes. One study 
done by Eriksen and Pettersson (2003) showed that 3-acetyl DON was metabolized to DON 
during the incubation period. However, no de-epoxidated metabolites were detected in the 
fecal incubation. Heilman (1997) observed that no metabolites of nivalenol (NIV) or DON 
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were formed in anaerobic incubation of the toxins with pig feces. However, after one week 
on a diet containing 2.5 or 5 ppm NIV, nearly all excreted NIV in feces had been de- 
epoxidated in five of six pigs. Thus, microbial adaptation to NIV and perhaps to DON as 
well might occur after exposure to these toxins. 
Therefore, DON can be de-epoxided to DOM-1 by microbial in the alimentary tracts in 
cow, chickens after in; vitro incubation of DON and contents of rumen and gastrointestine 
(Swanson 1987; He et al. 1992). It was found that gut microorganisms in rats and pigs can 
transform DON to de-epoxy metabolite (worrell et al. 1989;. Danicke et al. 2004). In 
human, it is reported that DON can not be degraded to de-epoxy metabolite (Eriksen and 
Pettersson 2003). 
(b) Bioavailability 
DON bioavailability is used to describe the fraction of an administered dose of DON 
that reaches the systemic circulation. By definition, when DON is administered 
intravenously, its bioavailability is 100%. However, when DON is administered via other 
routes, its bioavailability decreases (due to incomplete absorption and first-pass 
metabolism). 
Following administration of a single oral 10 mg/kg dose DON in male PVG rats, 
radioactivity excreted in the urine and feces accounted, respectively, for 25 and 64% of the 
administered dose within 96 h (Lake et al., 1987). 
DON was quickly absorbed with tm~ 4.0-5.3 h, but had a systemic bioavailability of 
only 7.5% due in part to its rapid and efficient metabolism by rumen microorganisms after 
oral dose of 5.0 mg/kg in sheep (Prelusky et al., 1985). Feeding dairy cows DON 
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contaminated diets for 5 d, approximately 20% of the DON fed was recovered in the urine 
and feces in the unconjugated forms as DOM-1 (96% of total DON excreted) and DON 
(4% of total). Preliminary data suggest that the remaining 80% may be excreted as a 
glucuronide conjugate ;(at least in urine) (Cote et al., 1986). 
In swine, after consuming DON contaminated feed, DON was rapidly absorbed while 
passing through the stomach and the upper small intestine. A dynamic laboratory model 
simulating the gastrointestinal (GI) tract of healthy pigs was used to evaluate the small 
intestinal absorption of DON. In vitro intestinal absorption of DON was 51 % of 170 µg 
DON ingested through contaminated (spiked) wheat. Most absorption occurred in the 
jejunal compartment. At the same time; activated carbon produced a significant reduction in 
the intestinal mycotoxin absorption (Avantaggiato et al., 2004). Eleven castrated male pigs 
weighing. 88.1 ~ 3.9 kg on average were adapted to a diet containing DON (4.2 mg 
DON/kg) over a period of 7 days. Feed was given restrictively with 1.1 kg per meal (two 
meals per day). DON was rapidly and nearly completely absorbed while passing through 
the stomach and the proximal small intestine. Maximum serum concentration appeared 4.1 
h after the DON-containing meal and half of the systemically absorbed DON was 
eliminated after 5.8 h. (Danicke et al., 2004). 
After intragastric (0.60 mg and 0.60 µCi DON/kg) administration of 14C-labeled DON 
in swine, DON was very rapidly absorbed, reaching neax peak plasma levels within 15-30 
min. Levels remained elevated (63-325 ng/ml) for approximately 9 hr, and began declining 
slowly (tli2 R = 7.1 h). The calculated systemic bioavailability was between 48 and 65% 
based on comparison of iv and intragastric AUC, although urinary and biliary recoveries 
indicated marginally greater absorption actually occurred (54-85%) (Prelusky et al. 1988). 
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Toxicokinetics of DON has been investigated in 16 castrated male pigs (41.5 ~ 2.0 kg) 
through feeding DON from naturally contaminated wheat (5.7 mg DON/kg) after chronic 
exposure (5-8 weeks) or one single oral dose (acute). The systemic absorption 
(bioavailability) of DON was estimated based on the area under the curves (AUC) after oral 
(chronic or acute) and intravenous application of pure DON (53 µg/kg). DON was rapidly 
absorbed following oral exposure and reached maximal plasma concentrations (C ,,,~) of 
21.79 and 15.21 ng DON/ml serum after (t mom) 88.4 and 99.1 min in the chronic (n = 5) and 
acute (n = 6) fed group, respectively. The mean bioavailability for free DON was 89% for 
the chronic group and 54%for the acute oral group (Goyarts and Danike, 2006a). 
The disposition of [14C] DON administered to hens as either a single oral dose or 
consumed in spiked feed over a 6-day period was deternuned by tracing the specific 
radioactivity of tissues and excreta. Following a single intubated dose of 2.2 mg [14C] DON 
with 2.4 µCi/bird, the toxin was found to be poorly absorbed; peak plasma levels (2-2.5 h 
post-treatment) accounted for less than 1% of the administered dose (Prelusky et al., 1986). 
As a conclusion, DON has poor absorption in sheep with systemic bioavailability only 
7.5% (Prelusky et al., 1985) and poor absorption in chicken with maximum plasma levels 
less than 1 % of the administered dose (Prelusky et al., 1986). Feeding cows for 5 days on 
DON contaminated foods showed systemic bioavailability of about 1%DON in urine (Cote 
et al., 1986}. DON could be rapidly absorbed while passing through the stomach and the 
upper small intestine in swine (Avantaggiato et al., 2004; Danicke et al., 2004) with 
systemic bioavailability of 50% from a single oral dose or 89% from chronic intake (4-8 
weeks) with maximal plasma concentrations (C mom) of 21.79 and 15.21 ng DON/ml serum 
after t,,,~ 88.4 and 99.1 min in the chronic (n = 5) and acute (n = 6) fed group, respectively 
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(Prelusky et al. 1988; Goyarts and Danike, 2006a) 
(c) Dist~ib ution 
After intravenous or oral dose of DON, how fast DON goes to tissue, what kind of 
tissue DON is distributed and tissue binding of DON are the research contents of 
distribution. 
Sprague-Dawley rats received a single dose of [ 14C] DON (5.0 ~ 0.1 mg/kg body 
weight, 5.5 ~ 0.1 microCi/kg) and the distribution of DON in body fluids was investigated 
over 72 h. DON and its metabolites were detectable in the plasma of rats with the highest 
levels at 8 h, at which time approximately 9% was bound to plasma protein (Meky et al., 
2003). 
The disposition of [ 14C] DON administered to hens as either a single oral dose or 
consumed in spiked feed over a 6-day period was determined by tracing the specific 
radioactivity of tissues and excreta. Maximum tissue residues were measured at 3 h in all 
tissues (liver, kidney, brain, heart, spleen, proventriculus, gizzard, small intestine) except 
for fat, muscle, -and oviduct, which occurred at 6 h postdosing. Among the organs, the 
highest activities were measured in kidney, liver, and spleen; however, these levels were 
equal to less than 500 ng DON equivalents/g tissue, and declined quickly. Clearance of 
radioactivity from tissue had an average half-life of 16.83 ~ 8.2 h (range 7.7-33.3 h, 
depending on the tissue). Elimination of the labeled toxin in excreta occurred rapidly; 
recovery of radioactivity accounted for 78.6, 92.1, and 98.5% of the dose by 24, 48, .and 72 
h, respectively. In continuously dosed birds fed 2.2 mg unlabeled DON for 6 days followed 
by 2.2 mg (1.5 µCi) [14C] DON for 6 days, accumulation of radioactivity in tissues did not 
occur. Maximum residual levels, which occurred in the kidneys, were only 60 ng DON 
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equivalents/g. Estimated level of residues contained in the edible tissues amounted to only 
13-16 µg DON/1.5 kg hen (Prelusky et al., 1986). 
After intravenous (iv) administration DON (0.5 mg/kg) in sheep, plasma levels were 
found to decrease biexponentially, showing a rapid distribution phase (t lie a = 12-23 min). 
DON was confined mainly to extracellular fluid, and did not appear to undergo any 
significant binding or uptake by tissue (Prelusky et al., 1985). After feeding sheep (DON 
tolerant animals) and pigs (DON sensitive animals) diets including DON, DON could be 
detected in their cerebral spinal fluid. After iv administration, DON was detected very 
rapidly (less than 2.5 min) in the CSC of both species, but whereas peak levels (t-max) 
occurred at 5-10 min in sheep, in swine it was 30-60 min. It would appear that the very 
rapid and extensive tissue distribution of DON in swine (V d gamma = 1.13 L/kg) may be 
slowing the rate of diffusion of the toxin into the CSF compared to sheep (V d p = 0.19 
L/kg) where the toxin is confined essentially to the extracellular compartment. A good 
relationship between blood and CSF DON levels was apparent in both species, although 
limitations in detection methods made it impossible to resolve a slow terminal phase 
(gamma) in swine CSF that was evident in the plasma profile after iv administration. The 
toxin could be detected in CSF for up to 20 hpost-dosing (Prelusky, 1990). 
(d) Excretion 
Urine and feces are main excretion routes after consumption of DON contaminated 
diet. In different animals, the ratio of DON in urine and feces is different. 
Following administration of a single dose of [14C] DON (5.0 ~ 0.1 mg/kg body 
weight, 5.5 ~ 0.1 µCi/kg) in Sprague-Dawley rats, a total of 37% of the administered DON 
was excreted in the urine (Meky et al., 2003). 
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After feeding dairy cows DON contaminated feed (66 mg/kg) for 5 day, urine and 
feces were the main excretion route. DOM-1, the de-epoxy DON, was found in milk at 
concentrations up to 26 ng/ml. Detectable concentrations of unconjugated DOM-1 were 
found in urine and feces up to 72 h after the last oral dose (Cote et al., 1986). 
Excretion of DON has been studied in sheep. After iv dosing (0.5 DON/kg b.w.), 
urinary DON levels declined in a biphasic fashion with an average elimination half-life 
(terminal phase) of 1.2 h, diminishing to baseline concentrations by 8 hr. Maximum urinary 
excretion rates for the two major metabolites identified (conjugated DON, conjugated 
DOM-1) occurred 0.5-1.5 h after dosing, exhibiting elimination half-lives of 2.2 and 3.1 h, 
respectively. Total recovery accounted for only about 66.5% of the dose: 63.0% in the urine 
and 3.5% in bile. Following oral administration (S.0 mg DON/kg body wt), urinary 
excretion rates of the major metabolites (DON, conjugated DON, conjugated DOM-1) 
reached maximum 6-9 hr post-treatment, and declined exponentially with t lie values of 3.2, 
4.0, and 5.0 h, respectively. Urinary and biliary recovery of administered DON averaged 
approximately 7.1 %: 7.0% in urine and 0.1 % in bile (Prelusky et al., 1986). 
The excretion kinetics of DON was investigated in swine. Serum DON levels declined 
slowly with an elimination half-life (t 1i2~) of 6.28 and 5.32 h after feeding castrated male 
pigs (n = 16, 41.5 ~ 2.0 kg) on DON from naturally contaminated wheat (16.6 mg DON/kg) 
chronic exposure or one single oral dose (acute) (Goyarts T and Danike, 2006) The pigs 
were fed a commercial diet with 3- acetyl DON added in a concentration of 2.5 mg/kg feed 
for 2.5 d (fed five times with feed corresponding to 2% of their body weight). The excretion 
of DON was mainly in urine (45 ~ 26% of the toxin ingested by the pigs) and only low 
amounts of metabolites of 3-acetyl DON (2 ~ 0.4%) were recovered in feces. De-
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epoxidated DON constituted 52 ~ 15% of the total amount of 3-acetyl DON-metabolites 
detected in feces. The remaining part in feces was DON. DON was still present in the urine 
and feces at the end of the sampling period 48 h after the last exposure with concentration 
between 58 and 131 ng/ml (Eriksen et al. 2003). 
DON was found in human urine through collecting urine sample from women in 
suspected high and low risk region in China. DON was detected in all 15 samples following 
beta-glucuronidase treatment and immunoaffinity columns (IAC) enrichment with the 
identity of DON being confirmed by mass spectrometry. The mean levels of DON from the 
suspected high and low exposure regions of China were 37 ng/ml (range 14-94 ng/ml) and 
12 ng/ml (range 4-18 ng/ml), respectively. This is estimated to correspond to daily DON 
exposures of l.1-7.4 µg/kg/day and 0.3-1.4 µg/kg/day, respectively. (Meky et al., 2003) 
(e) Tt~ansmission .into eggs and milk 
It is concerned if DON is transmitted to eggs and milk after cows and hens were fed on 
high DON contaminated diet. 
Corn contaminated with DON was added to the diets of three dairy cows for 5 d with 
dietary concentrations of DON averaging 66 mg/kg. Unconjugated de-epoxy DON (DOM- 
1), a metabolite of DON, was present in milk at concentrations up to 26 ng/ml. DON was 
not detected in the milk (Cote et a1., 1986). 
DON is seemingly not transmitted to egg after feeding hens DON contaminated feed. 
Twenty single comb white Leghorn hens, approximately 26 weeks of age, were individually 
housed in metabolic cages and fed a control or DON-contaminated (82.8 mg/kg) diet for 27 
days. No significant DON residues were found in the yolk, albumin and eggshell (Lun et 
al., 1986). The transmission of DON and of its metabolite de-epoxy DON into eggs has 
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been investigated by (Valenta and Danicke (2005). Laying hens were fed amaize-based diet 
with a DON concentration of 11.9 mg/kg dry matter for 16 weeks. Eggs were collected 
during weeks 2, 4, 8, and 16 of the experiment, and DON and its metabolite de-epoxy DON 
were analyzed in freeze-dried yolk and albumen. All samples were incubated with ~i- 
glucuronidase prior to extraction. Yolk and albumen were extracted with acetonitrile-water, 
and the extracts were purified with IACs after a precleaning step. The toxins were 
determined by high-performance liquid chromatography (HPLC) with UV detection. The 
detection limits of both toxins were S and 8µg/kg in freeze-dried yolk and albumen, 
respectively, corresponding to approximately 2.5 and 1µg/kg in fresh samples (calculated 
based on dry material of 51 %for yolk and 13% for albumin). The recovery of DON and de-
epoxy-DON in yolk spiked was 80% and 78%, respectively, and in albumin 77 and 72%. 
Neither DON nor de-epoxy DON or glucuronide conjugates of both substances could be 
detected in any of the samples. These results indicate that eggs do not contribute to the 
dietary DON intake of humans. 
As a conclusion, de-epoxication of DON is main metabolism of DON in 
gastrointestine, especially in ruminant's animals. After oral dose, chicken has a poor 
absorption with maximum plasma levels less than 1 % of the administrated dose (Prelusky 
et al. 1986). The free DON in urine in cow and sheep are ~l %and 7.5% of dose due to de- 
epoxidation of DON by microbial in rumen fruit (Cote et al. 1986; Prelusky et al. 1985). In 
pigs, the bioavailability of DON was much higher than in these animals. The mean 
bioavailability for free DON was 89% after chronic exposure (5-8 .weeks) of DON from 
naturally contaminated wheat based on the area under the curves after oral and intravenous 
application of pure DON (Goyarts and Danike 2006a). Distribution of DON to tissues is 
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very quickly at 3 h in all tissues, and accumulation of DON in tissues did not occur 
(Prelusky et al. 1986; Prelusky et al. 1990). At the same time, it is possible that DON does 
not be transmitted to eggs and milk or the concentration lower than detection limit results in 
no DON detected in eggs or milks (Lun et al. 1986; Cote et al. 1986). 
Biotransformation 
Besides some evidence showing that DON can be degraded to DOM-1 by 
microorganisms in rumen and gut of ruminant animals such as cow and sheep and in gut in 
animals such as pig and chicken (discussed in section "Gastrointestinal metabolism"), DON 
can be transformed in liver or intestine by UDP-glucuronosyltransferase (UGT) to DON 
glucuronide conjugate. At the same time, some evidence showed that DOM-1 can be 
transformed to DOM-1 glucuronide. 
Glucuronidation of DON has been found in rat liver. An isolated rat liver was perfused 
with. DON at a dose of 3 mg in a recirculating perfusion system. To identify glucuronide 
conjugates, equal amounts of bile samples, perfusate and liver homogenates in phosphate 
buffer solution (pH = 6.8), were incubated with and without a ~3-glucuronidase preparation 
and analyzed by thin layer .chromatography and capillary gas liquid chromatography-
chemical ionization mass spectrometry. A total of 40.4% of the administered dose of DON 
was found to be conjugated with glucuronic acid (perfusate 20.4%, bile 19.2%, liver 0.8%), 
while only 1.3 % of the parent DON (perfusate 1.1 %, bile 0.2%) was detected. The cleavage 
of DON glucuronide was demonstrated by incubating DON glucuronide containing bile 
samples and intestine contents under anaerobic conditions. To evaluate the effect of 
intestine microflora on the metabolism, glucaro- l , 4- lactone, a ~-glucuronidase inhibitor, 
was added to the bile incubation. After 3 days incubation, a total of 1µg DON/50 µL of bile 
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was detected in the bile sample with feces group, while only a total of 0.25 µg DON/50 µL 
was detected in the glucaro-1, 4- lactone group. This difference could be explained by the 
inhibitory effect of glucaro- l , 4- lactone on bacterial ~3-glucuronidase. From these findings 
in vivo a hydrolytic cleavage of conjugated toxin metabolites by the action of microbial ~3-
glucuronidase seems to be possible and free metabolites then undergo enterohepatic 
circulation. About 50% of dose is apparently reabsorbed after ~i-glucuronidase action 
(Garesis et al., 1987) 
Sprague-Dawley rats received a single dose of [14C] DON (5.0 ~ 0.1 mg/kg body 
weight, 5.5 ~ 0.1 µCi/kg) and the distribution of DON in body fluids was investigated over 
72 h. A total of 37% of the administered DON was excreted in the urine and DON- 
glucuronide was implicated as the major urinary metabolite based on reverse-phase HPLC 
analysis of [i-glucuronidase- and sulfatase-treated samples (Meky et al., 2003). 
Corn contaminated with DON was added to the diets of three dairy cows for 5 d. 
Dietary concentrations of DON averaged 66 mg/kg. After incubating urine with beta-
glucuronidase, the concentration of unconjugated DOM-1 increased by 7 to 15-fold 
whereas unconjugated DON increased 1.6 to 3-fold. Detectable concentrations of 
unconjugated DOM- l were found in urine and feces up to 72 h after the last oral feeding 
(Cote et al., 1986) 
After administrating intravenous and oral doses (0.5 and 5.0 mg/kg, respectively) in 
sheep, the metabolic formation of the glucuronide conjugate after iv and oral administration 
of DON appeared to occur quite efficiently (iv, 21 %; oral, 75%) with longer elimination 
half-lives than that of parent toxin. Detection in plasma of the de-epoxide metabolite, 
DOM-1, accounted for only a minor portion of the dose after either dosing regimen (iv, less 
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than 2.0%; oral, less than 0.3%), but occurring predominantly as the glucuronide conjugate 
(Prelusky et al., 1985). In male sheep following either intravenous (iv) or oral 
administration of DON at levels of 0.5 and 5.0 mg DON/kg body wt, respectively, the peak 
biliary excretion rate for glucuronide conjugated DOM-1 was found to occur within 1 hr 
postdosing, which rapidly declined to baseline levels by 5 h. Following oral administration, 
urinary excretion rates of the major metabolites (DON, conjugated DON, and conjugated 
DOM-1) reached maximum 6-9 hpost-treatment, and declined exponentially with t lie 
values of 3.2, 4.0, and 5.0 h, respectively. Urinary and biliary recovery of administered 
DON averaged approximately 7.1 %: 7.0% in urine (2.1 % DON, 3.6% conjugated DON, 
0.06% DOM- 1, 1.2% conjugated DOM-1) and 0.11 % in bile (predominantly conjugated 
DOM-1) (Prelusky et al., 1986). In lactating sheep, using a combination of radioisotopic 
counting and chromatographic detection techniques, the kinetics and metabolic fate of DON 
in plasma, urine and bile were studied, its major plasma metabolite, DON-glucuronide 
conjugate accounted for 13% of the plasma radioactivity levels (Prelusky et al., 1987). 
Five castrated ,male Swedish Landrace pigs were fed a commercial diet with 3 - 
acetyl DON added in a concentration of 2.5 mg/kg feed for 2.5 days. No traces of 3-acetyl 
DON or its de-epoxide metabolite were found in plasma, urine or feces. A significant part 
of the DON in plasma was in aglucuronide-conjugated form (42 ~ 7%). Only low amounts 
of metabolites of 3- acetyl DON (2 ~ 0.4%) were recovered in feces. De-epoxide DON 
constituted 52 ~ 15% of the total amount of 3- acetyl DON-metabolites detected in feces. 
The remaining part in feces was DON (Eriksen et al., 2003). 
Evidence obtained by comparing DON concentration of urine before and following ~3- 
glucuronidase treatment shows DON could be biotransformed in humans. An 
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immunoaffinity column (IAC)-HPLC method was subsequently developed to measure 
urinary metabolites, with a view to establishing aurine-based human biomarker. Urine 
samples were collected and tested from female inhabitants of Linxian County, China, a high 
risk region for esophageal cancer (OC) and an area of potentially high DON exposure, and 
Gejiu, a low risk region in China. DON was detected in all 15 samples following ~- 
glucuronidase treatment and IAC enrichment with the identity of DON being confirmed by 
mass spectrometry. The increase in parent DON recovered following enzyme treatment 
ranged from 1.2- to 2.8-fold (Meky et al., 2003). 
However, in some research, DON has been found to be poorly metabolized. After 
feeding 16 crossbred German Landrace X Pietrain castrated male pigs (41.5 ± 2.0 kg) on 
naturally contaminated wheat (5.7 mg DON/kg) with chronic exposure or one single oral 
dose (acute), glucuronide conjugation of DON was found in serum samples after oral 
exposure, but not after intravenous application. Dietary DON caused a significant increase 
in DON concentrations of urine and feces, whereby the metabolite de-epoxy DON was 
found only in the trials after pigs were fed DON contaminated diets over 6 weeks, no de-
epoxy DON was found with 4 weeks of DON exposure. (Goyarts T and Danike, 2006a). 
Similar results were found in an in vitro study. Through incubating Sprague-Dawley rat 
hepatic microsomes with DON and 14C-labelled uridine 5'-diphosphoglucuronic acid 
(UDPGA), no radioactivity was detected in the TLC zone where the glucuronide was 
expected. Three rats and one pig were dosed orally with 2 mg DON/kg and samples of their 
urine and feces were extracted and incubated with ~i-glucuronidase or with buffer only. No 
differences in DON or DOM-1 concentrations were detected between samples incubated 
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with or without ~-glucuronidase. Neither DON- nor DOM-1 glucuronides were formed 
either in in vitro liver systems or in vivo (Cote et al., 1987). It is possible no 
glucuronidation of DON found in their studies because the following reasons: 1) although 
the microsome was working in that p-nitrophenyl was used as a positive control to assess 
the validity of the glucuronidation system. However, the p-nitrophenyl glucuronide which 
served as a reference sand the expected DON glucuronide are expected to migrate at the 
same place at the TLC plate. Different compound glucuronide conjugate couldn't show at 
the same retention time. For example, using the same HPLC column, YMC-PACK C 18 
column, the retention time of DON glucuronide was 3.7 min using 6-9% methanol over 40 
min as mobile phase, while daidzein and genistein glucuronide were 15.5 and 22.1 min, 
respectively using 20-3 0% acetronitrile over 25 min as mobile phase (Zhang et al., 1999) 2) 
It is possible that the time (30 min) for microsome reaction was not long enough for 
glucuronidation. of DON. 3) pH 3.8 buffer used in ~i-glucuronidase reaction was too acidic. 
The optimal pH is 4.5-7 based on the ~i-glucuronidase resource. Therefore, incorrect 
chemical analytical method and conditions for enzyme reaction could result in no 
glucuronidation of DON in vitro and in the in vivo study of Cote et al. (1987). 
Glutathione- S-transferases (GSTs) could catalyze formation of a DON glutathione 
conjugate because the structure 12, 13 —epoxide could be the target of GST. Gouze et al. 
(2006) found that DON competitively inhibited 1-chloro-2, 4-dinitrobenzene (substrate) 
conjugation to GST, suggesting that DON is a substrate of GSTs. 
As a result, in ruminant animals, the major metabolite in plasma was the 
glucuronide conjugate of DON or the glucuronide conjugate of DOM-1 (Cote et al., 1986; 
Prelusky et al., 1987). The glucuronidation of DON has been found in pigs after feeding 3-
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acetyl DON at a concentration of 2.5 mg/kg feed for 2.5 days (Eriksen et al., 2003) and oral 
single exposure to DON from naturally contaminated wheat (Goyarts T and Danike, 
2006a). DON glucuronide has been found in human urine as a biomarker together with 
parent DON for biomonitoring DON exposure (Meky et al., 2003). No glucuronidation of 
DON was found in pigs after iv administration DON in Goyarts study (2006a), whereas 
glucuronidation of DON after oral exposure indicates DON could be conjugated in the 
intestine of pigs before absorption in this study. No glucuronidation of DON was observed 
in the Cote et al. (1987) study after incubation UDPGA, microsome, buffer and DON. It 
was possible that chemical analytical method (TLC) was not correct at all or incubation 
time was not long enough to produce DON glucuronide. Further studies should investigate 
whether DON can conjugate with glutathione. 
Toxicity 
Acute toxicity of DON is characterized by vomiting particularly in pigs, feed 
refusal, weight loss and diarrhea. Acute intoxication may produce necrosis in various 
tissues such as the gastrointestinal tract, bone marrow and lymphoid tissues. Subchronic 
oral exposure in experimental animals, pigs, mice and rats may also lead to reduced feed 
intake and slowed weight gain and changes in some blood parameters including serum 
immunoglobulins. Studies suggest that DON may have effects on the immune system. 
There are no indications of carcinogenic, mutagenic or teratogenic effects (`Opinion on 
Fusa~iufn Toxins', European commission, 1999). The following reviews the 
immunotoxicity of DON studied in different cell models, animal models and in human 
epidemiological studies to evaluate the risk of DON to human health. 
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Cellular and molecular effects 
(a) Inhibition of cell proliferation 
In vino, different. cell model has been used to study DON toxicity. It is observed that 
DON inhibited lymphocyte proliferation due to apoptosis and cytotoxicity. 
It is reported that DON binds to the ribosomal peptidyltransferase site in eukaryotic 
cells and inhibits protein and DNA synthesis, consequently exposure resulting in decreased 
cell proliferation and apoptosis. Shifrin and Anderson (1999) found that selected 
trichothecenes at 10 µM strongly activate JNK/p38 kinases and induce rapid apoptosis in 
Jurkat T cells. Although the ability of individual trichothecenes to inhibit protein synthesis 
and activate JNK/p38 kinases is dissociable, both effects contribute to the induction of 
apoptosis. At the same time, the research results show the peptidyltransferase site could be 
a regulator of both JNK/p38 kinase activation and apoptosis. 
Human and animal cell lines have been used extensively to study the mechanisms of 
in vitro toxicity of DON. Cell type is an important determinant of susceptibility to DON 
toxicity as well as determined ICso. Cetin et al. (2005) investigated DON cytotoxicity in 
mammalian cell lines, such as CHO-Kl, Caco-2, CS-O, V79, and HepG2 cell lines, to find 
the most sensitive cell line. Sensitivities of cell lines to DON were found in decreasing 
order of CHO-K1> V79>CS-O>Caco-2>HepG2 cells with final concentration of DON 
from 0.04 to 20 µg/ml. 
Meky et al. (2001) reported DON effectively inhibited mitogen-induced lymphocyte 
proliferation. Human peripheral mononuclear cells were obtained from healthy male and 
female blood donors. The cells were treated with phytohemagglutinin-p (PHA-p) at 10 
µg/ml or 0µg/ml, and DON was applied at a range 50-500 ng/ml. Cell cultures were 
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incubated in humidified chamber for 5 d and cell proliferation was evaluated by 
methylthiazol tetrazolium (MTT) assay. A decrease in proliferation was observed with 
DON at concentrations greater than 100 ng/ml and 50% inhibition at 216 ng/ml. However; 
DON had no effect on the viability of unstimulated lymphocytes at these concentrations as 
measured by the MTT assay. In another study, the lymphocytes were treated with 5 µg/ml 
PHA or 1 µg/ml Pokeweed mitogen (PWM). The lymphocytes were cultured for 72 h and 
cell proliferation was evaluated by [3H]-thymidine assays. The ICSOs of DON for the 
proliferation responses of human lymphocytes were 124 ng/ml (female) and 130 ng/ml 
(male) after PHA and 113 ng/ml for both female and male after PWM. Therefore, there 
were no statistically significant differences in sensitivity to the DON between lymphocytes 
from females and males (Thuvander et al., 1999). 
U-937, a human monocyte-like histocytic lymphoma (CRL-1593.2) was differentiated 
into macrophages using PHA and was treated with different concentrations of DON for 24 
h. The cytotoxic effects of DON on U937 macrophage cells were measured using MTT 
assay. Cell proliferation was significantly reduced at concentrations of 50-1000 ng DON/ml 
(Sugita-Konishi et al., 2001). 
The effects of DON in the human K562 erythroleukemia cell line were evaluated. 
DON inhibited K562 .cell proliferation. The ICsos were 650 ng/ml and 474 ng/ml after 
measured by MTT colorimetric assay and BrdU uptake with 48 h treatment. Fluorescent 
propidium iodide staining and flow cytometry revealed DON induced programmed cell 
death at the highest concentration of DON (23.7 µg/ml), particularly chromatin 
condensation and hyperchromasia. Protein synthesis inhibition may play a role in DON 
induced apoptosis (Minervini, 2003). 
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Uzarski et al. (2003) reported DON induced apoptosis an d reduced B cell proliferation 
in an immature (CH31, WEHI-23) an d mature cells lines of B cells (CH12.LX). DON 
induced cytotoxicity and apoptosis in WEHI-23 cells after exposure at 100-1000 ng/ml for 
18h, with EC50 at 500 ng/ml for apoptosis and 300 ng/ml for cytotoxicity, respectively. 
Additionally, immature and mature B cells are equally sensitive to DON induced cell death. 
Investigating activation marker expression among subpopulations of human T cells from 
freshly collected blood found DON inhibited lymphocyte proliferation in the early cell 
cycle and its inhibition is before or in conjunction with CD25 (the IL-2 receptor) expression 
(Johannisson, et al. 1999). 
Mikami et al. (2004) demonstrated the cytotoxicity of DON in porcine primary 
cultured hepatocytes and analyzed the mode of cell death. Livers were obtained from 
healthy 1-month old LWD piglets and porcine hepatocytes were cultured in vitro. The 
primary hepatocytes were treated with. 100, 10, 1, 0.1 or 0.01 µg DON/ml. Cell viability 
was measured by MTT assay. Transmission electron microscopy was employed, and lactate 
dehydrogenase (LDH) release and caspase-3 activity were measured to analyze the mode of 
cell death. The cell death of the hepatocytes was observed with DON at 100 µg/ml and 10 
µg/ml groups starting at 6 h after DON was added. There was dose-dependent effect of cell 
death in 24 h treatment for all tested concentrations. The dead hepatocytes showed 
characteristics of apoptosis. LDH was released from apoptotic hepatocytes, and increased 
caspase-3 activity was seen in higher concentrations DON groups. Additionally, albumin 
secretion was reduced in all treatment groups, and the concentrations of albumin in the 
medium in DON 100, 10 and 1µg/ml groups were similarly low. The reduction of albumin 
secretion from the hepatocytes intomedium was due not. only to the loss of hepatocytes by 
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apoptosis but also to the inhibition of protein synthesis. Decreased concentrations of serum 
protein and albumin may be secondary to the reduced feed uptake. These results indicate 
that DON induced apoptosis through the caspase-3 activation pathway and caused 
functional disorder in porcine hepatocytes. Further researchswill be needed to determine if 
DON induced functional deficit in hepatocytes requires apoptosis. WCH-17 and PLHC-1 
could be used as cell lines to study functional change of liver after DON exposure. 
As a result, DON inhibited mitogen-induced lymphocytes proliferation with IC50 at 
216 ng/ml (Meky et al. 2001). Cancer cell lines, such as K562 erythroleukemia cell line and 
different B cell lines have been used investigated DON cytotoxicity. DON inhibited cell 
proliferation in different cell lines with similar ICSo values from 216 ~ 650 ng/ml (Meky et 
al. 2001; Minervine 2003; Uzarski et al. 2003). Cytotoxicity of DON in hepatocytes has 
been observed and dead cells show apoptosis. DON exposure influences albumin in the 
medium (Mikami et al. 2004). Further research need to determine if DON induced 
functional deficit in hepatocytes requires apoptosis. 
(b) Hematological problems 
Hematotoxicity induced by xenobiotics involves altered blood cell production or 
function either in bone marrow or at the level of circulating blood cells. Human white blood 
cell progenitors, red blood cell progenitors and platelet progenitors are the target of the 
cytotoxic effects of DON. 
Froquet et al. (2001) researched DON toxicity on human hematopoietic progenitors. 
Human umbilical cord blood samples were collected in heparinized tubes from placentas 
obtained after normal deliveries. Lineage cells were identified with immunocytochemical 
staining. A decrease of growth percentage of platelet progenitors and red blood cells 
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progenitors is detectable for 2.5 X 10"~ M DON, whereas DON exhibits cytotoxic effects at 
2.5X10"~ M on white blood progenitors. Froquet et al. (2003) also researched whether DON 
inhibited the clotting process and compared the sensitivities of circulating blood cells and 
hematopoietic progenitors to DON. The results show the coagulation disturbances induced 
by DON were not statistically different from control in vitro for prothrombin time, activated 
partial thromboplastin time and thrombin time assays at measured concentrations (10"5 M, 
10-6 M and 10-8 M). The aggregation initiated by ADP or collagen did not show any 
statistically significant modification in the presence of increasing concentrations of DON. 
Red blood cells from human umbilical cord blood did not show significant haemolysis in 
the presence of increasing concentration of DON. A 50% decrease in leucocyte number was 
observed for 10-5 M DON. In vitro data confirmed that DON effects were likely to be 
predominantly on progenitor cell rather than on circulating mature blood cells. Further 
research will be needed to determine if the effect of DON is on differentiation or 
proliferation of progenitor cells, or both. 
(c) Inhibition or stimulation of cytokine production 
A number of studies suggest that mycotoxins are potent immunomodulators. 
Depending on the dose, timing and route of exposure, mycotoxins can be 
immunostimulatory or immunosuppressive agents. Immune modulation is related to 
'changes in cytokine production. Elevated cytokine expression may play an important role in 
the pathophysiologic effects of DON and other trichothecenes. Cytokine superinduction by 
protein synthesis inhibitors is likely to involve transcriptional and/or post transcriptional 
mechanisms. 
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Zhou et al. (1997) found acute oral DON (5 and 25 mg/kg b.w.) exposure enhances 
mRNA expression of several cytokines, including IL-1 ~, IL-2, IL-4, IL-6, IFN-y and IFN-a 
in spleen, Peyer's patches (indicators of systemic and mucosal immune compartments, 
respectively), and other organs in male B6C3F1 mice. The effects were more pronounced in 
spleen than in the Peyer's patches. Serum levels of IFN-a, IL-6, and IFN-y were elevated 3 
h after exposure to 25 mg/kg DON, thus suggesting that elevation of splenic and Peyer's 
patch mRNA abundance correlated with increases in systemic production of these 
cyto Ines. 
To better understand molecular mechanisms by which DON superinduces cytokine 
gene expression, Li et al. (1997) studied the posttranscriptional effects of this mycotoxin on 
interleukin-2 (IL-2) gene expression in murine EL-4 thymoma cells stimulated with phorbol 
12-myristate 13 -acetate and ionomycin (PMA +ION). Northern analysis revealed that 
doses of 50 to 500 ng/ml DON superinduced IL-2 mRNA expression in a dose- and time-
dependent manner in a synchronous model where DON was added at onset of PMA +ION 
stimulation. In accordance with the mRNA levels, IL-2 production was significantly 
elevated in the presence of 50 to 250 ng/ml DON. Superinduction of IL-2 mRNA was also 
observed in a delayed synchronous model (DON added 20 h after PMA +ION stimulation) 
and an asynchronous model (DON added 20 h after PMA + ~ ION stimulation and removal). 
To assess .the effects of DON (500 ng/ml) on IL-2 mRNA half-life, three transcriptional 
inhibitors (Actinomycin D, 5, 6-dichloro-beta-D-ribofuranosyl-benzimidazole, cyclosporin 
A) were used in the delayed synchronous model. The results suggest that DON can 
superinduce IL-2 at both the mRNA and the protein level and that this superinduction can 
be explained, in part, by posttranscriptional mechanisms .such as enhanced mRNA stability. 
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Transcription factor NF-~cB plays a critical role in regulation of transcription of several 
cytokine genes. DON exposure can enhance NF-~cB binding activity by inhibiting the 
synthesis of I~cBa, which is a negative regulator of NF-~cB. Besides NF-~cB, activator 
protein-1(AP-1) is another critical transcription factor involved in transcriptional regulation 
of IL-2 and IL-6 gene expression. AP-1 is composed of members of the Jun (Jung, c-Jun 
and JunD) and Fos families (c-Fos, FosB, Fra-1 and Fra-2), which bind to the TPA response 
element (AP-1 site). It was demonstrated by gel supershift assay that DON (250 ng/ml) 
preferentially affected phosphorylated c-Jun, Jung, c-Fos and Fra-2 binding activities, 
whereas it did not alter Jun D and Fra-1 binding. These increasing binding activities are 
associated with enhanced AP-1 transactivation, which may contribute to cytokine 
dysregulation and immunotoxic effects associated with exposure to trichochecene 
mycotoxins such as DON (Li et al., 2000) 
Evidence for cytokine dysregulation was found by Meky et al. (2001). Blood was 
collected from healthy donors and mononuclear cells were isolated. Duplicate cultures were 
prepared with or without phytohemagglutinin-p for each .concentration of DON (0, 100, 200 
and 400 ng/ml). Supernatants were collected every 24 h for 3 d. Cytokine levels were 
analyzed in supernatants by ELISA. The results show cytokine production could not be 
detected in cells that were treated with toxin alone or which did not receive PHA 
stimulation. Short-term treatment of PHA-stimulated lymphocytes with DON modulated 
the kinetics of IL-2, IL-4 and IL-6 production. IL-2 levels were up to 12-fold higher in 
comparison to control levels at DON concentrations of 200 and 400 ng/ml 72h after 
treatment. IL-4 levels were only slightly elevated and IL-6 levels were slightly inhibited by 
these DON concentrations. At the lower DON concentration of 200 ng/ml, IL-2 levels were 
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elevated with a concomitant mild elevation in IFN-y. At 400 ng/ml, IL-2 levels were 
significantly elevated until 6 d post treatment. 
Effects of DON on the production of the cytokines have been investigated in a human 
macrophage model (Sugita-Konishi et al., 2001). U-937, a human monocyte-like histocytic 
lymphoma, was differentiated into macrophages by incubating with PHA. Subsequently, 
the U-937 macrophage cells were incubated with different concentrations of DON alone or 
in combination with 0.2 µg/ml lipopolysaccaride (LPS). At appropriate time intervals, the 
cells were analyzed for IL-6, TNF-a and IL-8 production using ELISA. In the absence of 
LPS, DON at 500 or 1000 ng/ml upregulated TNF-a production as early as 3 h and up to 6 
h, whereas 100 to 1000 ng/ml of DON significantly increased production of IL-6 from 3 to 
24 h and IL-8 from 6 to 48 h. In the presence of LPS, DON at 500 or 1000 ng/ml markedly 
induced TNF-a and IL-8 production. However, for IL-6, 100 ng/ml of DON potentiated 
LPS-induced IL-6 production, while 500 or 1000 ng/ml of DON suppressed the LPS-
induced IL-6 production. As a result, DON induces or superinduces cytokines production 
even at DON concentrations that are cytotoxic (as shown in section `inhibition of cell 
proliferation'). In another study, the monocytic U937 cells were used as a model for human 
alveolar macrophages. The IL-8 cytokine in U937 cells peaked (0.6 ~ 0.2 µg/ml) at the very 
same DON concentration (250 ng/ml) that inhibited SO% of the cells' protein synthesis 
suggesting that IL-8 can be used be an additional index for cytotoxicity in mononuclear 
phagocytes (Instances et al., 2004). 
These data suggest DON has potent effects on human lymphocyte cytokine production, 
which could be used to investigate DON exposure in human population. Low dose exposure 
of DON (SO ng/ml) induced increased IL-2 levels with. mitogen stimulation and involved 
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transcriptional (increase mRNA level) and posttranscriptional (increase mRNA stability) 
mechanisms. DON exposure (100. ng/ml) also induced increased IL-6 and TNF-a level and 
chemokine IL-8 level (Li et al., 1997; Sugita-Konishi et al., 2001). Since IL-2 therapies 
have been associated with rheumatoid arthritis and vitilligo development (Massarotti et al., 
1992; Richards. et al., 1992) and IL-2 may mediate the number of T helper cells, which 
induce B lymphocytes to differentiate into plasma cells which secret IgA. Increased serum 
IgA levels were found to associate with autoimmune disease in mice because the immune- 
complex was deposited in kidney, similar to human IgA nephropathy (Bondy and Pestka, 
1991). Therefore, increased serum IL-2 after DON exposure could be used as a biomarker 
to monitor chronic disease such as human Ig A nepharopathy associated with DON 
exposure. At the same time, DON exposure induces IL-6 levels, which also stimulate 
plasma cells to secrete. IgA (Sugita-Konishi et al., 2001). Therefore, DON exposure 
stimulates mitogen- induced lymphocytes secretion of these cytokines at lower 
concentrations. It is not clear if IL-2 and IL-6 could be used as biomarkers in plasma after 
chronic DON exposure because the level of lymphocyte stimulation and resultant cytokine 
levels would probably differ from the well-controlled levels in vitro. 
(d) Changes in immunoglobulin 
Human peripheral mononuclear cells were obtained from healthy male and female 
humans; pokeweed mitogen was added to the cultures at 1µg/ml. The lymphocytes were 
cultured for 7 d and the medium was refreshed. Antibody production was tested using 
ELISA kit. The results show that immunoglobulin (Ig) A, IgG and IgM production were 
inhibited by exposure to DON. The ICSo of inhibitory effects of DON on Ig production was 
0.37 µM, 0.39 µM, 0.4 µM, for IgG, IgM and IgA, respectively (Thuvander et al., 1999). 
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Another study in pigs showed similar results. ConA stimulated pig peripheral blood 
mononuclear cells were exposed to DON for 72 h with ICso of inhibitory effects on Ig 
production of 0.41 µM, 0.28 µM and 0.24 µM, respectively (Goyarts et al., 2006b). 
However, in vivo study (animals were fed DON and Ig levels measured in plasma or 
serum) or in vivo-vitro study (animals were fed DON, lymphocytes removed, and Ig levels 
measured in supernatant of cultured lymphocytes), IgG, IgM and IgA levels were inhibited 
or increased after DON exposure depending on species and exposure dose and time. In 
C57BL6 mice, a subchronic dose of 0.071 mg DON/kg b.w. for 3 d per week for 4 weeks 
(corresponding to daily mean intakes of 0.2 ppm contaminated feed applied for four 
consecutive weeks) provoked increases in plasma IgA (Gouze et al. 2006). In German 
Landrace x Pietrain pigs (both sexes), serum IgA levels was significantly increased after 
they were fed wheat naturally contaminated with DON (6.5 mg/kg diet) for 11 weeks ad 
libituyn, with no change in restrictively fed pigs fed DON (Goyarts et al., 2005b). In the 
follow-up study, Goyarts et al. (2006) found IgA, IgM and IgG in the supernatant of 
cultured lymphocytes were not significantly affected after dietary DON exposure (5.7 
mg/kg diet, 550 g diet) over 4 weeks or as a single dose (pigs fed restrictively). However, 
serum IgM and IgG were significantly increased in pigs fed a single dose of DON, although 
IgA was not affected (Goyarts et al., 2006b) 
Variation in results that DON influences immunoglobulin levels could be due to 
various other factors than DON that may influence Ig production in animals, such as 
exposure time and dose, or cytokine levels. Firstly, IL-2, a THl cytokine expressed in T- 
lymphocytes following activation, plays a central role in T and B cell growth and 
differentiation. IL-2 can act as a stimulus for synthesis of IgA and also act in concert with 
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other cytokines to enhance IgA production. Ingestion of DON results in elevated serum IgA 
and IgA nephropathy in mice, which may be mediated through the superinduction of gene 
expression of several cytokines that include IL-2 and IL-6. Secondly, immunoglobulin 
secretion is dependent on the type of lymphocytes used. For example, IgA and IgG 
secretion was highest in ConA stimulated compared to LPS stimulated or unstimulated 
cultures (Pestka et al., 1990). Thirdly, IgA is important for mucosal immune system. 
Transcytosis of IgA antibody across epithelia is mediated by the poly-Ig receptor, a 
specialized transport protein. It is reported that DON exposure in the intestine modulated 
the activities of intestinal transporters (Maresca et al. 2002). Therefore, it is possible the 
serum IgA levels was increased partly due to dysfunction of poly-Ig receptor. Additionally, 
different species have different responses to DON exposure. For example, DON caused 
more diverse xmmunoglobulin disturbances in pigs than in mice. 
Take together, DON influence IgA, IgG and IgM levels after exposure to natural 
contaminated DON. Serum IgA level was significantly increased in mice fed 0.2 ppm 
DON for 4 weeks (Gouze et al. 2006). In pig, serum IgA level was not influenced after fed 
restrictively with DON contaminated food at 5.7 mg/kg diet as a single time or 6.5 mg/kg 
diet for 11 weeks (Goyarts et al., 2005b; Goyarts et al., 2006b). Serum IgG and IgM was 
observed to increase after single dose at 5.7 mg/kg diet in pig (Goyarts et al., 2006b). 
Effects of DON on immunoglobulin need further study to decide its effect in human. 
(e) Inhibition of macrophage ~nicrobicidal killing and NK cells activity 
Macrophage phagocytosis of microorganisms is important in host immunity and 
activated macrophages kill ingested pathogens by production of reactive oxygen and 
nitrogen metabolites. DON shown previously to exert immunosuppressive effects on the 
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immune system. was examined for in vitro effects on some functions of marine peritoneal 
macrophages (Ayral et al., 1992). Peritoneal exudate cells (macrophage cells) in peritoneal 
cavity of Swiss Female mice (6 ~ 8 weeks) were collected. The cells were pre-incubated for 
4 h with the mycotoxin (0.1 1000 ng/ml). At concentrations that did not affect cell 
viability (based on Specific Lactate Dehydrogenase test), DON suppressed microbicidal 
activity of phagocytic cells against model microbes, opsonized Saccha~omyces ce~evisiae. 
DON inhibited phagocytosis, microbicidal activity and superoxide anion production at 1 
ng/ml whereas phagosome-lysosome fusion was reduced above 100 ng DON/ml. These 
results suggested that microbicidal activity inhibition by DON was independent of non- 
oxidative pathway (phagosome-lysosome fusion) impairment. 
Berek et al. (2001) investigated the effects of DON on lymphocyte blast transformation, 
activity, antibody-dependent cellular cytotoxicity (ADCC, destruction of antibody-coated 
target cells by NK cells) and natural killer (NK) cell activity. Human peripheral blood 
monoclear cells (PBMC) were isolated from healthy blood donors. The cultures were 
incubated in the presence or absence of mitogens: PHA and Con A. [3H] thymidine assay 
were used to investigate lymphocyte blast transformation (T lymphocyte proliferation 
assays). The research compared the difference between incorporated activity of transformed 
cells and control cells (without mitogeris). In the ADCC test, 51Cr labelled freshly collected 
Rh (D, C) - positive O red blood cells (RBC) were used as target cells and PBMC 
macrophages as an effector in a 1:10 ratio. The reaction was mediated by RBC-specific 
anti-D antibodies. The amount of released SiCr in supernatant was determined using a 
gamma counter after incubation at 37°C for 16 h. In NK assay, 51Cr- labeled K562 cells 
were used as the target and PBMC used as effector in a 1:50 ratio. The amount of 
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radioactivity released into culture supernatants was determined and the results were 
expressed as percentage of inhibition after incubation at 37°C for 4 h. The investigated 
concentrations of DON were 0.11800 ng/ml. The results showed that DON exerted 
immunosuppressive effects on human peripheral blood mononuclear cells in vitro 
manifested as depressed T or B lymphocyte activity and inhibited NK cell activity at 50 ng 
DON/ml, suggesting that protection against tumor development may also be attenuated. 
Taken together, these results. show DON exposure exerted an inhibitory effect on the 
resident macrophage cell and NK cells at concentrations which occur in human peripheral 
blood. Natural killer cells are an early component of the host response to virus infection. 
Inhibition of NK cell activity occurs after DON exposure, the levels of some viruses will be 
much higher in the early days of the infection. Macrophage cells as phagocytic cells 
provide a first line of defense against infection and act as one of important antigen- 
presenting cells. Inhibition of macrophage cell activity and lymphocyte activity will cause 
inhibition of microbicidal killing and alteration of THl-T~ balance. 
(~ Induction of inflammation-associated genes 
DON and other trichothecene mycotoxins mediate a broad range of immunotoxic 
effects via the. induction of inflaimnation-associated genes in leukocytes. Moon and Pestka 
(2002) tested the hypothesis that DON induces cyclooxygenase-2 (COX-2) gene expression 
in macrophages and they determined that DON-increased COX-2 is regulated at the level of 
mitogen-activated protein kinases (MAPKs). Exposure of the marine macrophage cell line 
RAW 264.7 to 50-250 ng/ml DON for 24 h markedly enhanced the production of 
prostaglandin E 2 (PGE2), a major COX-2 metabolite. PGE2 elevation was preceded by 
increases in COX-2 mRNA (2 h) and COX-2 protein (15 h) in DON-treated cells. DON 
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induced rapid (15 min) and persistent (up to 240 min) phosphorylation of extracellulax, 
signal regulated protein kinases 1 and 2 (ERKl/2) and p38 MAPK as well as a rapid (15 
min) but transient (up to 60 min) phosphorylation of c-Jun N-terminal kinases 1 and 2 
(JNKl/2). The ERK inhibitor PD98059 and p38 inhibitor SB203580 suppressed DON- 
induced PGEZ and COX-2 protein expression, whereas impairment of JNK function by 
transient transfection with a dominant negative (dn) JNK vector had no effect on COX-2 
protein expression after DON treatment. In cells transfected with aCOX-2 promoter- 
luciferase construct, PD98059- and SB203580-, but not dnJNK-treatment, suppressed 
DON-induced luciferase transcription. DON also increased COX-2 inRNA stability, and 
this was inhibited by PD98059 but not by SB203580. Taken together, these results indicate 
that DON-induced PGE2 production and COX-2 expression by elevating transcriptional 
activity and inRNA stability. Enhanced transcriptional activity was modulated by ERK and 
p38 signaling .pathways, whereas mRNA stability was promoted exclusively by DON- 
activated p38 phosphorylation. These data provide insight into possible general 
mechanisms by which DON and other trichothecenes upregulate proinflaininatory genes 
and impart immunotoxicity. 
Animal studies 
(a) DONtoxicity effect on inflammation 
Kinser et al. (2004) reported acute exposure to DON modulates gene expression 
profiles in murine spleen by microarray analysis. B6C3F1 mice were treated orally with 25 
mg DON/kg body weight. Two hours later, the spleens were collected for microarray 
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analysis. DON was found primarily to modulate genes associated with immunity, 
inflammation, and chemotaxis. 
Endotoxin is a biologically active component of the Gram-negative bacterial cell wall 
that exists as complexes of LPS and protein. Mononuclear phagocytes are main targets for 
LPS. Islam and: Pestka (2006) reported LPS priming sensitized a host to DON-induced 
proinflammatory cytokine induction and apoptosis in mice. Male B6C3F1 Mice (7 weeks) 
were primed with LPS (1 mg/kg b.w.) i.p. and were treated with DON (0. S to 25 mg/kg 
b.w) p.o. 8 h later. For cytokine protein and rriRNA determination, blood was collected at 2 
h after DON treatment. The results show the minimum DON doses for inducing. IL-1 a, IL- 
~i, IL-6 and TNF-a serum proteins and mRNAs in spleen were significantly lower than the 
DON doses required for vehicle-primed mice. DON doses from 2 to 25 mg/kg b.w. 
significantly induced plasma IL-1 ~3, and LPS pre-treatment lowered the threshold for _DON 
to 0.5 mg/kg. An identical pattern was observed for IL-6 in plasma. DON at 12.5 and 25 
mg/kg b.w. but not lower doses induced TNF-a; LPS-pre-treatment lowered this threshold 
to 2 mg/kg in plasma. Although IL-1 a was not detectable in serum of any experimental 
group, thresholds for induction on splenic IL-1 a mRNA by DON alone was 12.5 mg/kg 
b.w.; thresholds for DON-induced IL-1 a mRNA decreased to 5 mg/kg following LPS 
priming. Increased apoptosis in the thymus was observed in mice primed with LPS i.p. at 
DON concentration of 12.5 mg/kg. As a result, LPS potentates the effects of DON in vivo 
and in vitro. These results indicate DON exposure could increase sensitivity in chronically 
sick or malnourished individuals. 
Salmonella ente~itidis, a bacterium causing food-borne . infection, is often used for 
studying mechanisms of bacteria invasion into intestinal cells in vivo and in vitro. S. 
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ente~itidis infects intestinal cells at first, and then transfers to the other organs via blood 
stream. The effect of DON on Salmonella ente~itidis infection was investigated in male 
Balb/c mice. Mice were given water containing 2 ppm DON or no toxin for 3 weeks. The 
results of bacteria counting showing that Salmonella increased more rapidly in the 
mesenteric lymph node, liver and spleen of the DON-treated mice than in untreated mice. 
These finding suggest that DON promotes invasion or/and growth of Salmonella in the 
lymph node, liver and spleen. These results indicate that DON reduces the resistance of the 
organs and enhanced infection through inhibition of cell-mediated immune function (Hara- 
Kudo et al., 1996). 
Atroshi et al. (1994) investigated the effect of dietary exposure to DON on host 
resistance and serum immunoglobins of normal and mastitis lactating inbred Han:NMRI 
mice. The influence of DON on mastitis was evaluated by examining, pathologically and 
immunologically, the degree of infection in the presence of S. hyicus and M. avium. After 
feeding a single dose of DON (12.5 mg/kg b.w.) or a week of dosing of DON (6.25 mg/kg 
b.w. per day), the mice were infected with mastitis. The levels of serum IgA, IgG and IgM 
were increased in mice fed 12.5 mg/kg b.w. DON. A single treatment of DON and infection 
didn't show significantly difference from control, whereas one-week treatment of mice with 
DON had a significant mediating effect on the severity of mastitis. Macroscopic 
examination of the mammary glands revealed severe mastitis in 70% of the glands of 
control mice, compared with only 20% in the glands of the DON treatment- mice. These 
results indicate that DON is able to modulate the acute-phase response to infection through 
non-specific host-resistance factors. 
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(b) DON toxicity on humoral and cellular immunity 
Weanling male Swiss Webster mice were administered by gavage 0.75, 2.5, and 7.5 
mg of DON per kg body weight once per day for 5 weeks. Serum antibody (IgIV~ levels to 
sheep red blood cells (SRBC) were significantly reduced in the treatment groups compared 
to the control groups. Plaque-forming cell (PFC) numbers were also lower in the treated, 
groups compared to the control groups. Furthermore, DON at a dose of 0.75 mg/kg b.w. 
resulted in a significant increase in the albumin, albumin/globulin ratio and a decrease in 
the alpha-2 globulin fraction compaxed to the control groups. Administration of 7.5 mg/kg 
b.w. of DON resulted in deaths, due to toxicity, in all animals of this group within 3 weeks. 
These findings indicate a potential effect of DON on the immune system which could have 
serious implications for humans (Tryphonas et al., 1984). Tryphonas et a1. (1986) gave male 
Swiss Webster mice sublethal doses (0, 0.25, 0.5 and 1 mg/kg b.w./day corresponding to 0, 
1, 2 and 4 ppm of DON in feed for 5 weeks to study DON effects on humoral and cellular 
immunity. DON at 1.00 mg/kg resulted in a statistically significant reduction in the serum 
levels of alpha 1 and alpha 2-globulins, an increase in total serum albtuniii, and a reduction 
in feed consumption and body weight gain compared to the control group. The 0.50 mg/kg 
dose of DON resulted in significantly reduced serum levels of alpha 2- and beta-globulins 
while a significant reduction of feed consumption was evident only during Week 4. 
Similarly, body weight gain in this group of mice was significantly reduced during Week 2 
but increased to normal levels during Week 3 and remained parallel to the control for Week 
4 and 5. Both levels (0.50 and 1.00 mg/kg) of DON resulted in a reduced, dose-related, 
time-to-death interval following a challenge with L. monocytogenes and increased 
proliferative capacity of splenic lymphocyte cultures stimulated with the 
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phytohemagglutinin P (PHA-P) mitogen compared to the control group of mice. The 0.25 
mg/kg dose of DON did not have any significant effects on the parameters studied. A 
reasonable estimation of a 'no effect' level for ixnxnunologic effects in mice based on these 
and previous immunological studies would seem to be between 0.25 and 0.50 mg/kg b.w. 
/day. 
Male Balb/c mice (4~6 weeks) were used to investigate the immunosuppressive effect 
of DON. Mice were daily fed DON for 1 or 2 weeks at doses of 2.5 to 100 ppm in the diet. 
The 100ppm exposure of DON in diet was lethal to all animals within a few days. After oral 
administration of DON to mice, liver and kidney weights were not changed whereas thymus 
weight was reduced significantly at concentration >10 ppm. Histologically, the structure of 
the thymus was damaged and the high doses produced an atrophy of this organ. The spleen 
weight was reduced less than thymus weight. Serum levels of anti-sheep red blood cell 
antibodies (in vivo T dependent synthesis of anti-sheep red blood cells antibodies) were 
significantly reduced with dose-response effect. The stimulation of B and T cells by 
mitogens was depressed more for thymic cells than for splenic cells. In vino, DON 
inhibited cell proliferation estimated by [3H] thymidine incorporation: marine splenocytes 
were more sensitive than XP human fibroblasts. These results indicate that the immune 
system is the primary target of DON to~city (Robbana-Barnat et al., 1988). Thymus weight 
reduction and structural damage after DON exposure suggested children could be more 
sensitive to DON exposure than adults because in the fetus and the juvenile the thymus is 
the source of large numbers of new T lymphocyte. In mature individuals, the development 
of new T cells in the thymus slows down and T cell numbers are maintained through T cells 
outside the central lymphoid organs. 
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(c) DON interactions with other mycotoxins 
The effects of dietary exposure to DON and zearalenone (ZEA) at naturally occurring 
levels (DON 0.5, 5 and 25 ppm; ZEA 10 ppm; DON 5 ppm or 25 ppm plus ZEA 10 ppm) 
on the immune function were evaluated for 2-3 and 8 week feeding periods in B6C3F 1 
weanling female mice, and the effects of immune parameters after exposure to DON and 
ZEA in combination were evaluated. The immune assays included resistance to Liste~ia 
nZonocytogenes, plaque-forming cell (PFC) response to sheep blood cells and delayed 
hypersensitivity response by measuring the degree of footpad swelling response to keyhole 
limpet hemocyanin. The results showed that dietary DON depressed the plaque-forming 
response to .sheep red blood cells, the delayed hypersensitivity response to keyhole limpet 
haemocyanin and the ability to resist Listeria monocytogenes after 2 weeks feeding. 
Resistance to Liste~ia was reduced to a greater extent by co-administration of DON and 
ZEA than by DON alone, whereas the ability of DON to inhibit the delayed 
hypersensitivity response was significantly lessened in the presence of ZEA. 
Immunosuppression can thus result from ingestion of F. g~aminea~unZ-infected agricultural 
staples, the suppression being attributable to interactions between direct immunotoxic 
effects of DON and ZEA and, nutritional effects associated with DON-induced food refusal. 
Dietary exposure to naturally occurring levels of DON and ZEA caused significant effects 
on host resistance, humoral immunity and cell-mediated immunity in the mouse (Pestka et 
.al., 1987}. 
As a result, DON immunotoxicity was influenced by exposure time and interaction 
with other mycotoxins. For example, the dietary DON depressed the plaque-forming 
response and delayed hypersensitivity response after 2 weeks feeding, whereas no effect at 
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these terms after 8 weeks feeding. At the other hand, interaction with ZEA .influences DON 
toxicity. Take delayed hypersensitivity response as an example, after 3 weeks feeding, 
DON alone decreased the delayed hypersensitivity response, whereas no effect at this term 
after interaction with ZEA. DON immunotoxicity interaction with other mycotoxins such as 
aflatoxin or fumonisin, need further research. 
(d) Other DON toxicity research 
Instanes and Hetland (2004) reported that DON did not increase levels of allergen- 
specific IgE or IgGl in a mouse model (female Balb/c mice, 6-8 weeks old). However, 
DON reduced cellular protein synthesis, proliferation and survival rate dose-dependently in 
human colonic (Caco-2), lung (A549) and monocytic (U937) cell lines and increased the 
production of IL-8 in U937 cell line. These results suggest that DON may have toxic effect 
on human alveolar macrophages and epithelial cells in lungs and colon. So DON may have 
some potential environmental problem at work places where cereals are processed and food 
harvest. 
Male C57BL6 mice (6 weeks old) were fed low doses of DON through 4 wks (0.014, 
0.071, 0.355 and 1.774 mg of DON/kg b.w. applied three times for a week) corresponding 
to daily average intakes of 0.05, 0.2, 1 and 5 ppm of contaminated feed. Plasma IgA 
concentrations were significantly increased by 66%, 48%and 47% in animals receiving 0.2, 
1 and Sppm DON. No significant change occurred in serum IgG and IgM concentrations in 
any treatment group. Liver biotransformation enzymes were examined. The two liver 
microsomal mixed-function oxidasees ethoxyresorufin O- deethylase (EROD) and 
methoxyresorufin O-demethylase (MROD) were unaffected, whereas pentoxyresorufin 0- 
depentylase(PROD} activity was increased in 0.05, 0.2 and 1 ppm DON treatment groups. 
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Cytochrome P450 (P450) 2b subfamily expression was significantly increased in the liver 
of mice receiving 0.2 and 1 ppm DON, and P450 2b expression had significant correlation 
with PROD activity. western Blot analysis of cytosolic GST a, µ or ~ subfamilies 
expression demonstrated an induction (56-65%) of the GST ~ subfamily in liver of mice 
receiving these doses of DON, a slight increase in GST a expression was observed at 1 ppm 
DON, whereas GST µ remains unchanged.. A significant competitive inhibition of DON on 
1-chloro-2, 4-dinitrobenzene (substrate) conjugation in vitro suggests that DON will bind to 
the same site on the enzyme and could likely to be a potential substrate of liver cytosolic 
GST ~ subfamily. These results also indicate that a subchronic low dose exposure could 
cause changes in the liver metabolism of xenobiotics (Gouze, et al. 2006). Further study 
should investigate DON metabolism by GST. In theory, the 12, 13 epoxide group 
characterizing all epoxy-trichothecene toxins could be a target for these for GST conjugate 
enzymes. 
Pigs are the most sensitive animals to DON. Ingestion of naturally contaminated DON 
induced vomiting and reduced feed consumption. Goyarts et al. (2005) investigated the 
effects of a chronic DON intoxication on performance, hematological and serum parameters 
of pigs when diets were offered either ad libitum or restrictively. Female and castrated male 
crossbred German Landrace X Pietrain pigs were fed DON concentrations of 395 µg/kg diet 
and 16643 µg/kg diet for control group and DON contaminated diet group, respectively. 
The growth experiment covered the live weight range between 26 and 100 kg and lasted 11 
weeks in total. The results shows there were not significant differences in feed intake, live 
weight gain and feed to gain ratio in restrictively fed groups. In ad libitum fed control 
group, feed intake was 2.90 kg/day, live weight gain 987 g/day and feed to gain ratio 2.77 
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kg/kg; in ad libitum fed DON group, consumed 15% less feed and gained 13% less live 
weight, while the feed to gain ratio was unaffected. The sex of pigs significantly affected 
live weight gain and feed intake. Castrated males of the ad libitum fed ~ groups had a 
significantly higher feed consumption and the live weight gain than the females, while 
under restrictive feeding conditions no marked differences. Restrictively DON fed animals 
needed more time to consume the restrictive feed than the control group. A total of 85% of 
the control pigs consumed their feed within the first hour after feeding, while only 3 9% of 
the DON group did this. At the same time, serum IgA levels show significant difference in 
ad libitum groups, while no difference in restrictive groups. Additionally, serum clinical-
chemical parameters, such as total protein, glutamate dehydrogenase, y- 
glutamyltransferase, aspartate aminotransferase and creatinine kinaseconcentrations, were 
not affected by dietary treatment, ~ except concentrations of alkaline phosphatase 
significantly lower in the ad libitum DON group than its counterparts. As a result, in 
restrictively fed groups, there was no significant different in feed consumption, sex, serum 
IgA levels and serum clinical chemical parameters in both control and DON groups, except 
longer time to be required consume restrict feed in DON group than control group. In ad 
libitum groups, there was significant different in these terms between DON group and 
control group. These results indicated ad libitum and restrictive consumption influenced. the 
feeding consumption, and influenced DON concentrations, and then influence 
hematological parameters. 
Low dose DON exposure (0.2 ppm diet) in mice induced liver Cytochrome P450 
(P450) 2b subfamily and GST ~ subfamily expression suggested low doses of DON causes 
changes in the normal liver metabolism of xenobiotics. Therefore, cytochrome P40 and 
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GST ~ could be used as biomarkers to monitor the exposure of DON in human and liver 
enzyme induction after DON exposure need further research in other species (Gouze et al., 
2006). In Goyarts et al, (2005) study, in restrictively fed groups DON exposure has less 
influence to pig in serum IgA levels and serum clinical chemical parameters than these 
terms in pigs in ad libitum group. Investigation of the difference between restrictively 
consumption and ad libitum after chronic consumption of low dose DON contamination 
food need further research in other species. 
Potential effects on the human population 
Outbreaks of DON mycotoxicosis are associated with consumption of mold damaged 
food products all over the world, in countries such as India and China. The main clinical 
symptoms are nausea, vomiting, dizziness, abdominal pain and diarrhea; some cases show 
headache and fever (Pestka, et al., 2005 review). In an epidemiological study, an outbreak 
in India in 1989 was associated with the consumption of bread made from mold-damaged 
wheat. The disease was not age or sex specific. Evidence of mold damage of wheat 
consisted of the presence of fungi, such as Fusa~iun'Z s~. and trichothecene mycotoxins, 
such as DON. 
In order to obtain a no observed adverse effect level (NOAEL) and acceptable daily 
intake (ADI) for human, the data in animal studies could be useful. If taking DON toxicity 
to humoral and cellular immunity as an endpoint (Tryphonas et al., 1986), sublethal doses 
of 0, 0.25, 0.5 and 1 mg/kg b.w./day corresponding to 0, 1, 2 and 4 ppm DON in food were 
investigated after 5 weeks of feeding male Swiss Webster mice. The results showed that the 
0.25 mg/kg dose of DON did not have any significant effects on the serum levels of alpha 1 
and alpha 2-globulins, serum albumin, feed consumption and challenge with L. 
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monocytogenes. Combining uncertainty factors (interspecies and interindividual, for a 
factor of 46, Kodell and Gaylor 1999 NYAcad Sci), NOAEL or ADI would be 5.4 µg/kg 
b.w. /day for humans. In another study (Gouze et al., 2006), male C57BL6 mice were fed 
0.014, 0.071, 0.3 5 5 and 1.774 mg of DON /kg b.w., corresponding to daily average intakes 
of 0.05, 0.2, 1 and 5 ppm contaminated feed for 4 weeks, plasma IgA levels were 
significantly increased by 66%, 48% and 47% in groups fed 0.071, 0.3 5 5 and 1.774 mg of 
DON /kg b.w. If taking IgA levels as an endpoint, NOAEL or ADI will be 0.3 µg/kg b.w. 
/day for humans. The threshold for serum IgA elevation was at an oral dose of 0.071 mg/kg 
given three times a week for 4 weeks, which seems quite a low dose for human, about 20 
µg per person. It is possible that increased serum IgA levels is a specific and early 
toxicological endpoint. At the cellular level, DON (50 ng/ml) regulated T helper cell 
cytokines, such as IL-2 (Li et al. 1997), and DON (100 ng/ml) stimulated macrophages to 
secrete IL-6 (Sugita-Konishi et al., 2001). IL-2 and IL-6 can stimulate B lymphoblast to 
differentiate to plasma cell to secrete IgA. Therefore, monitoring serum IgA is a realizable 
method to investigate the environmental DON exposure. NOAEL or ADI will be 0.3 µg 
DON/kg b.w./day for humans with serum IgA as endpoint. 
It is of obvious concern that exposure to DON might produce chronic effects such as 
reduced weight gain and immunotoxicity in human population. Nowadays, a lot of studies 
have been done in animal models to help investigate the immunotoxicity of DON. Feeding 
male C57BL6 mice 0.071 mg of DON /kg b.w. for 4 weeks (corresponding to 0.2 ppm diet) 
significantly increased serum IgA (Gouze et al., 2006). Feeding male Swiss Webster mice 
1 ppm diet for 5 weeks did not have significant effects on the a-1 and a-2 globulins, total 
serum albumin, feed consumption, body weight gain and; proliferation capacity of splenic 
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(Tryphonas et al., 1986). Combining uncertainly factors (interspecies and interindividual), 
the safe guideline maximum level 500 µgDON/kg diet (Codex Alimentarius Commission 
FAO/WHO, 2003) is still too high because of increase of serum IgA levels after 200 
µgDON/kg diet exposure in mice. Further research should investigate what level of increase 
of IgA seriously affects human health. 
Epidemiological studies have not yet targeted immunotoxicity of DON in humans. In 
lab situation, cells were cultured in medium and cell growth conditions were 
environmentally stable, whereas the human system is more complicated. In cell lines, in 
recent studies, the exposure concentration of DON was 501000 ng/ml (some up to 10 
µg/ml) in order to research effects of DON on cell proliferation inhibition and cytokine 
levels. Significant inhibition of cell proliferation was reported at 100 ng DON/ml and 
cytokine level (e.g. IL-2) upregulation at 50 ng DON/ml (Meky et al. 2001; Li et al., 1997). 
Investigation of DON exposure through detection of DON and its glucuronide in human 
urine in high risk region found that the concentrations of DON were lower at 37ng/xnl (this 
amount included DON glucuronide) (Meky et al. 2003). Therefore, it is an interesting 
question as to whether the level of DON in human serum is really of concern in terms of 
cytokine dysfunction and lymphocyte proliferation inhibition. 
Conclusion 
(a) Summary 
DON is a mycotoxin produced by Fusarium g~amineaNum and Fusarium culmorum. It 
is commonly found on cereals grown in the temperate regions of America, Europe and Asia 
(review by WHO 1990). The substance is a very stable compound; it does not degrade at 
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high temperatures and is found in raw and processing cooking of food (Castells et al., 
2005). It could be a DON detoxification route to incubate seeds with biotransforming 
microorganisms from the gut in chicken/ ruminant animals or the soil (He et al. 1992; 
Swanson 1987; Binder et al. 1998). Essential oils could be useful as alternatives to food 
preservatives currently in use (Velluti et al. 2004). 
Numerous methods have been developed to monitor DON contamination in foods or 
detect DON residue in tissue, such as chemical method GC, HPLC-UV, LC-APCI-MS, and 
screening methods ELISA and cell proliferation assay. ELISA assay has a lowest detect 
limit with 0.2 ng/ml in buffer without clean up after extraction (Ngundi et al. 2006), 
however ELISA has crossreactivity between DON and other trichothecenes (Krska et al. 
2001}. Immunoaffinity column enrichment and HPLC-MS/iJV detector has a very low 
detect limit at 12-20 ng/ml can detect individual compound specifically (Janes and Schuster 
2001; Meky et al. 2003). The cheapest method is clean up using alumina and charcoal SPE 
column combined with cell proliferation assay. At the same time, it was reported this 
method has a good correlation with chemical method such as GC and HPLC (Landgren 
2005). 
DON has poor absorption in sheep with systemic bioavailability only 7.5% 
(Prelusky et al., 1985) and poor absorption in chicken with maximum plasma levels less 
than 1 % of the administered dose (Prelusky et al., 1986) and about 1 % free DON in cow 
urine (Cote et al., 1986). DON could be rapidly absorbed while passing through the 
stomach and the upper small intestine in swine (Avantaggiato et al., 2004; Danicke et al., 
2004) with systemic bioavailability of 50% from a single oral dose or 89% from chronic 
intake (4-8 weeks) with maximal plasma concentrations (C mom ) of 21.79 -and 15.21 ng 
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DON/ml serum after (t ,,,~) 88.4 and 99.1 min in the chronic (n = 5) and acute (n = 6) fed 
group, respectively (Prelusky et al. 1988; Goyarts and Danike, 2006a). DON can be 
degraded, to DOM-1 by microorganisms in rumen and gut of ruminant animals such as cow 
and sheep and in gut. in animals such as pig and chicken (Swanson 1987; Prelusky et al. 
1986; He et al. 1992; Danicke et al. 2004), DON can be transformed in liver or intestine by 
UDP-glucuronosyltransferase (UGT) to DON glucuronide conjugate in cow, sheep, rat, pig 
and human(Cote et al. 1986; Prelusky et al. 1987; Mety et al. 2003; Eriksen et al. 2003). At 
the same time,_ some evidence showed that DOM-1, the metabolite in gastrointestine of 
DON, can be transformed to DOM-1 glucuronide (Prelusky et al. 1986). Further study 
should investigate whether DON can conjugate with glutathione. 
DON exposure (0.2 ppm diet) has immunostimulatory effects resulting in elevated 
serum IgA levels (Gouze et al. 2006) and upregulation of the expression of many immune 
related genes such as those coding for COX 2 at 50 ng/ml (Moon and Pestka, 2002) and 
cytokines (THl and TH2) (eg. IL-2, 50 ng/ml) (Li et al., 1997). DON exposure could 
severely injury actively dividing tissues including bone marrow, lymph nodes, spleen and 
thymus resulting in immunosuppression by lowering T and B cells numbers (ICSo 216 500 
ng/ml) (Meky et al., 2001; Uzarski et al., 2003), decreasing Ig G and IgM levels at 118 
ng/ml (Thuvander et al., 1999), decreased resistance to pathogens (2 ppm DON in drinking 
water) (Hara-Kudo et a1., 1996), inhibition of antibody response to model antigens (sheep 
red blood cells) (2 ppm diet) (Tryphonas et al., 1986). Additionally, low dose exposure of 
DON could change hepatic xenobiotic metabolism (Gouze et al. 2006). If immunotoxicity 
is taken as an endpoint, a human NOAEL may be estimated at 0.35.4 µg/kg b.w. (Gouze 
et al. 2006; Tryphonas et al., 1986). 
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(b) Future work 
It is often difficult to relate experimental results of studies of the toxicology of DON 
with what occurs under real life situations because invariably there are other related 
trichothecenes present. 3-acetyl DON and 15-acetyl DON are often present at levels of 10- 
20% of DON. These toxins are metabolized to DON at varying rates and to varying 
degrees. Nivalenol and T-2 toxins were found in varying quantities in the food poisoning 
outbreak in India in 1989. Fumonisin B 1 and DON were extracted from non-harvested 
maize (Cvetnic et al., 2005). This information at least suggests immunotoxicity studies of 
DON need to include interactions between DON and other mycotoxins, such as aflatoxin 
and fumonisin. 
There are few reports on developing a simple method to screen the human population in 
high-risk region of DON exposure. Until now, the only reported method is through 
detection of DON in human urine by HPLC method. Low dose DON exposure (0.2 ppm 
diet) in mice induced liver Cytochrome P450 (P450) 2b subfamily and GST ~ subfamily 
expression suggested low doses of DON causes changes in the normal liver metabolism of 
xenobiotics. Therefore, cytochrome P40 and GST ~ could be used as biomarkers to monitor 
the exposure of DON in human after DON exposure. Serum IgA level was observed to 
increase after 0.2 ppm DON exposure in mice indicating serum IgA could be a sensitive 
biomarker in human (Gouze et al., 2006). Additionally, the serum IgA levels were 
-increased partly due to dysfunction of poly-Ig receptor. Thorough investigation of IgA 
levels in intestine could help explain or exclude this reason. 
Determining the exposure concentrations of DON to cells relevant to real-life exposure 
is a crucial point when cell culture, bioassays are employed to study the immunotoxicity of 
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DON. Future work should determine realistic doses when in vitro models are used for 
further toxicological investigations as possible alternatives to whole animal testing. Few 
epidemiological studies have examined immunotoxicity of DON in humans. The needed 
information would include the occurrence of DON in foods and human clinical samples 
associated with outbreaks of gastroenteritis and immune suppression, and comparison of 
incidences of acute (e.g. gastroenteritis) and chronic disease (e.g. IgA nephropathy) in 
geographical areas of high and low DON exposure. 
60 
MATERIAL AND METHODS 
Chemicals 
DON, uridine 5' -diphosphoglucuronic acid (trisodium salt, UDPGA), uridine 5' - 
diphospho-N-acetylglucosamine (sodium salt, UDPAG), L-glutamine, rat liver microsomes 
and Sephadex LH-20 were all obtained from Sigma Chemical Co., St. Louis, MO. RPMI-
1640, gentamicin and fetal bovine serum (FBS)-heat inactivated were all from Invitrogen 
Corporation (Carlsbad, California). ~-glucuronidase, type H-2 from Helix Pomatia was 
obtained from Sigma Chemical Co., St. Louis, MO. HPLC grade methanol and acetonitrile 
obtained from Fisher (Fair lawn NJ) 
MTS, [3- (4, 5-di~nethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl} - 2-(4- 
sulfophenyl) - 2H -tetrazolium, inner salt was purchased from Promega Corporation, 
Madison, WI. Trypan blue solution (0.4%) was obtained from Sigma Chemical Co. St. 
Louis, MO. 
DON glucuronide synthesis and purification 
DON glucuronide synthesis 
The final standard incubation mixture contained 0.3 mM DON, dissolved in water. 
Other reagents were 15 mM UDPGA, 50 mM Tris HCl buffer (pH 7.4), 5 mM MgCl2, and 
0.25 mM UDPAG to activate microsomes. The reaction mixture was prewarmed for 30s 
before adding 5 mg/mL rat liver. microsomes. The volume of reaction mixture was 0.5 ml. 
The reaction mixtures were inverted a few times, and incubated at 37°C in a water bath for 
1 h. Blank incubations contained all ingredients without UDPGA or microsomes. 
Incubation was .terminated by addition of cold methanol (2-fold excess volume) and 
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centrifuged for 10 .min at 10,000 rpm at room temperature (Eppendorf centrifuge 5415 C, 
Eppendorf North America, Inc. Westbury, CT) to pelletize the microsomal protein. 
Purification of DON glucuronide 
The 75 ml supernatant was concentrated by rotary evaporation (R-114; BUCHI, 
Flawil, Switzerland). Sml concentrated mixture was collected and then 1 ml of 
concentrated reaction mixture was loaded onto a Sephadex LH-20 column (2.8 X 47.2 cm, 
bed vol. 292 ml) each time. The column was equilibrated and eluted with water. Fractions 
of 4 ml were collected and analyzed by spectrophotometer (Beckman DU 520 UV-Visible 
Spectrophotometer, Beckman Instruments Inc. Fullerton, CA) at 220 nm. All peak fractions 
eluting at fraction number 16-21, 23 -25 and 3 3 -3 7 (fraction volume of 4 ml) were 
combined. ~i-glucuronidase hydrolysis (in 37 °C water bath overnight, incubated with equal 
volume 0.2 M sodium acetate buffer (pH 5.5) and 50 µl on 10,000 unit ~3-glucuronidase , 
type H-2 from Helix pomatia., obtained from Sigma Chemical Co., St. Louis, MO) showed 
that fractions number 23, 24 and 25 included DON glucuronide. Therefore, these fractions 
were collected, lyophilized (Virus Unitrap II freeze-dryer, Gardiner, NY) and then 
dissolved in water for further HPLC purification. The aqueous residue of DON glucuronide 
and some impurity (7 ml, 4 ml + 3 ml) was subjected to an analytical scale purification 
HPLC system by successive injections of 100 µl volume. The peaks corresponding to DON 
glucuronide (retention time 14 min) were combined and lyophilized to yield approximately 
1.5 mg of material for MS, NMR analysis and cell culture. HPLC (HP 1050, Hewlett 
Packard, Broken Arrow, OK) was equipped with photodiode array detector. Peaks were 
scanned across 190 nm to 400 nm. A reverse phase Atlantic dCig column (5 µm, 250 X 4.5 
mm) fitted with an in-line filter (Waters, Milford,, MA) was used to separate DON 
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glucuronide from impurities. Mobile phase A was ultrapure water (Milli-Q, filtered by 0.2 
µM filter); mobile phase B was acetonitrile. The gradient was initially 0% B, linear to 
12%B over 15min, switching to 50%Bat 17 min, and holding at 50% B until 25 min then 
returning to initial conditions. Flow rate was 0.9 ml/min. 
Identification of the structure of the synthesized DON glucuronide 
The purity of the biochemically synthesized and purified DON glucuronide was 
determined using HPLC with photodiode array detection. Identification of the DON 
glucuronide was performed using HPLC-UV spectrum from 190 to 400 nm, comparative 
HPLC chromatograms between microsome reaction mixture and blank controls, R-
glucuronidase hydrolysis, mass and nuclear magnetic resonance (NMR) spectrometries. 
~3- glucuronidase hydrolysis combined with HPLC -UV detection In order to 
determine if rat liver microsomes catalyzed formation of DON glucuronide in vitro, 
reaction mixture after centrifugation was dried under N2 to evaporate methanol, and then 
dissolved in 1.5 ml distilled deionized (dd) H2O. Point two of ml reaction mixture residue 
was diluted with 0.3 ml ddH20 and incubated with 0.5 ml 0.2 M sodium acetate buffer (pH 
5.5) and 50 µl ~i- glucuronidase(no enzyme for control) at 37°C water bath overnight. C18
Sep-Pak cartridge (Waters, Milford, MA) was used to clean-up samples after ~3-
glucuronidase hydrolysis. After loading the sample, the cartridge was washed with 1 ml 
H2O and 1 ml 1 %methanol. DON or DON glucuronide eluted with 1 ml of 50% methanol. 
At the same time, blank incubations, which contained all ingredients without UDPGA or 
microsomes, were followed every step as the above. HP 1050 series (Hewlett-Packard, 
Broken Arrow, Oklahoma) HPLC equipped with photodiode array detector was employed 
to detect the compounds. YMC-PACK C 1 g column (10 cm X 4.6 mm, 5µm particle size) 
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was used with a gradient of 6- 9% methanol over 40 min and a flow rate of 1 ml/min. Four 
different chromatographs were obtained: microsome reaction mixture, blank controls 
(without UDPGA or without microsome) and after ~3- glucuronidase hydrolysis reaction. 
Photodiode array detector was used to check the wavelength across 190 nm to 400 nm for 
each peak. 
Mass spectrometer MS analyses were performed with a Shimadzu LCMS-2010 
system (Shimadzu, Kyoto, Japan), equipped with an electrospray ionization source (ESI) 
and atmospheric pressure chemical ionization (APCI) source. A myoglobin and MRFA 
mixture was used for tuning and routine calibration of the instrument. Purified sample was 
dissolved in 100% methanol about concentration at 2 mg/ml. The samples were introduced 
into the eletrospray interface through an untreated fused-silica capillary with a 50 µm i.d. 
and 190 µm o.d. All samples were introduced via 5µl loop injection. 
Nuclear magnetic resonance spectrometry (NMR) All samples and spectra were run 
on a Varian VXR-400 NMR spectrometer equipped with a Bruker magnet, probes, shim 
supply with Varian console and software (Varian Inc. Palo Alto, CA). Samples of DON 
standard and purified DON glucuronide were dissolved in approximately 0.8 ml of d-
methanol and placed into NMR microtubes. Proton and carbon NMR spectra were acquired 
on both samples. 
Extinction coefficient determination for DON glucuronide 
DON standard (lmg, Sigma Chemical Co., St. Louis, MO) was dissolved in 1 ml 100% 
HPLC grade methanol and then diluted to concentrations from 10 to 100 mg/L. Purified 
DON glucuronide (0.53 mg) was dissolved in lml 100% HPLC grade methanol and then 
diluted to 10.6 to 106 mg/L. Samples were transferred to a 1 ml cuvette and UV absorption 
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measured at 220 nm by spectrophotometer (Beckman DU 520 UV-Visible 
Spectrophotometer, Beckman Instruments Inc., Fullerton, CA). 
Comparative immunotoxicity of DON and DON glucuronide 
Sample preparation 
DON standard (1 mg) was dissolved in lml methanol and diluted to 100 µg/ml stock 
solution and stored at -20°C until use. Aliquots of DON and/or DON glucuronide purified 
by HPLC were evaporated under N2 and dissolved in cell culture medium with 1.7% 
ethanol (v/v) and 0.3% DMSO (v/v), and then filtered through 0.2 µm PVDF syringe filter 
(4 mm, Alltech. Co., Nicholasville, KY) into sterile microcentrifuge tubes and diluted 
serially twice with the medium plus 1.7% ethanol and 0.3% DMSO. 
Cell culture 
K-562 cells (ATCC® number CCL-243TM Manassas, VA) were cultured in RPMI 
medium 1640 (1 X) supplemented with 25 mM HEPES buffer (pH 7.2), 2 mM L-glutamine, 
10% heat inactivated fetal bovine serum and 50 µg/ml gentamicin. The cells were 
maintained in 75 cm2 cell culture flasks in a humidified incubator at 37 °C in an atmosphere 
of 5% CO2-95% air mixture. The cells were subcultured three times each week by 
replacement of fresh medium by starting new cultures at 2 X 1 OS viable cells/ml. Cell 
suspensions of the cells were counted using a hemocytometer and 0.4% trypan blue. 
To determinate if there was a linear relation of cell numbers to optical density in MTS 
proliferation assay, single cell suspension containing cell densities ranging from 2X 103 to 
2.6X 105 cells with viability of 98 %per 200 µl medium/well were added to 96-well plates 
after serial dilution in sterile centrifuge tubes. The medium was allowed to equilibrate for 
half an hour, and then the MTS bioassay was performed immediately. To determine the 
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number of seeding cells, single cell suspension containing cell densities ranging from 407 
to 65000 cells per 200 µl medium/well were added to 96-well plates after serial dilution in 
sterile centrifuge tubes. MTS bioassay was performed after 48 h incubation of cells at 37 °C 
in an atmosphere of 5% CO2-95% air mixture. There was a good correlation after seeding 
407 to 25000 cells to wells for 48 h incubation. 25000 cells/well was selected for cell 
proliferation assay because a lower number of cells would not produce sufficient absorption 
after CellTiterTM was added; because DON inhibits cell proliferation, a strong absorption 
from the control cells improves the sensitivity of the assay. 
The MTS cell proliferation assay 
MTS cell proliferation assay is a colorimetric method for determining the number of 
viable cells in culture in multiwell plate format. The quantity of formazan product as 
measured by the amount of 490nm absorbance is directly proportional to the number of 
living cells in culture. 
The day of assay, cells in log phase growth were transferred to a 15 ml centrifuge tube 
and centrifuged 7 min at 1100 rpm, and the pellet was suspended and diluted to 2.5 X 105
cells/ml (viability > 95 %). A 100 µl volume of cell suspension was added to each well of 
96 well microtiter plate except the blank wells (Corning Inc. NY). A 100 µl sample of 
DON/glucuronide was added to cell cultures in triplicate. The final concentrations of DON 
and DON glucuronide were 0.13 -13 5 µM, 1.1-270 µM, respectively. One row was used as 
control for cell growth (no DON or DON glucuronide) and one set of triplicate wells 
contained medium alone as a blank control. The total volume for each well was 200 µl. 
Equal concentration of DON and DON glucuronide at 0.5µM, 1.3 µM and 8.4 µM were 
combined to investigated if DON glucuronide influcences DON toxicity. The microtiter 
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plate was incubated 48 h at 37°C in 5% CO2 /95% air and cell proliferation was determined 
by MTS cell proliferation assay. Ce1lTiter 96® Aqueous One Solution Reagent (15 µl) was 
added to each well and swirled to mix. The plate was incubated for 90 min at 37°C in a 
humidified 5% CO2 /95% air atmosphere and read on an EL340 microplate reader (Bio-Tek 
Instruments, Winooski, VT) at 490 nm. A reference wavelength of 630 nm was used to 
subtract background contributed by cell debris and other nonspecific absorbance. The 
absorption of samples wells was converted to a percentage of control and plotted against the 
concentrations to obtain dose-response curves. Concentrations of DON that caused 50% 
inhibition of cell proliferation (IC50) were derived by power trend line because of highest 
correlation between DON concentrations and cell proliferation in the power trend line 
(Microsoft Office Excel, Seattle, WA). The data were expressed as the mean of three 
independent experiments each with triplicate wells per treatment. 
Trypan blue exclusion 
The viability of the cells was estimated by the trypan blue exclusion method. The 
reactivity of trypan blue is based on the fact that the chromopore is negatively charged and 
does not interact with the cell unless the cell membrane is damaged. Therefore, all the cells 
that exclude the dye are viable. 
As with the MTS assay, the microtiter plate was incubated 48 h at 37°C in 5% 
CO2/95% air. Trypan blue solution (0.4%) was added to cells at the ratio of 1:1. Cell/dye 
mixture was pipetted to hemocytometer slide and viewed with a light microscope at 100 
times magnification. The live cells in each sample were converted to the percentage of live 
cells found in control incubations, and plotted against the DON/glucuronide concentration 
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to obtain dose-response curves. ICsos were derived by power trend line. The data were 
expressed as the mean of two independent experiments each with duplicate wells. 
DON and DON glucuronide addition and morphological and number observation 
The morphological observation and cell enumeration by inverted microscope was done 
at 48 h after DON and DON glucuronide addition. The Nikon TMS-F microscope systems 
have high-resolution Nikon Coolpix 995 digital cameras (Fryer Company INC, Scientific 
instruments, Huntley, IL) for the direct electronic capture of images. 
Statistical analysis of data 
All statistical analyses were performed using SAS 9.1 (Cary, NC, USA). One—way 
analysis of variance (ANOVA) was employed to compare immunotoxicity difference 
between DON and DON glucuronide and their combination, and to compare methods 
different between MTS cell proliferation assay and Trypan blue exclusion. A value of 
p<0.05 was considered significantly different. 
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RESULTS 
DON glucuronide characterization and identification 
DON glucuronide (DONGLU) synthesis incubations resulted in the formation of a 
peak with a retention time of 3.7 min on HPLC showing a similar UV spectrum to that of 
DON (Fig 4A, Fig 5). Preliminary identification showed that ~3- glucuronidase hydrolysis 
caused the formation of product with retention time of 13.1 min and UV spectrum similar to 
the DON standard (Fig 4A, 4B, Fig 5). Comparative HPLC chromatography of DON 
glucuronide reaction mix without UDPGA or without microsomes showed that only in the 
complete reaction mix was there a peak at a retention time of 3.7 min with a UV spectrum 
similar to DON, putatively DONGLU (Fig 4A, 4C and 4D). 
DON glucuronide was purified by Sephadex LH-20 gel filtration. ~3-glucuronidase 
hydrolysis showed that fractions 23, 24 and 25 contained a product that was hydrolyzed to 
DON, putatively DONGLU (Fig 6A, Fig 7). When microsomal mixture was purified by a 
Sephadex LH-20 gel, DON was not eluted by water. Methanol and water solution of > 10% 
methanol (50% better) was required to clean the gel after collecting fractions including 
DON glucuronide. Preliminary study showed DON was eluted by 10% methanol from the 
Sephadex LH-20 gel after loading partial purified DON material (extract from extracted 
from F. g~aminea~um culture in our lab) (Fig 7 B). 
After Sephadex LH-20 fractionation, DON glucuronide was further purified by 
analytical HPLC. The retention time of DON glucuronide was at 14.6 min and the spectrum 
of DON glucuronide was similar to DON. The retention time of DON standard was 23.4 
min (Fig 8) 
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Fig 4. Chromatograms showing DON glucuronide (DONGLU) (A) and the appearance of 
DON after DONGLU hydrolysis by 20 h ~3-glucuronidase treatment (B). (C) Incubation 
reaction without microsomes and (D) Incubation reaction without UDPGA show no 
DONGLU formation. YMC-PACK C i g column (10 cm X 4.6 mm, 5µm particle size) was 
used with a gradient of 6- 9% methanol over 40 min, flow rate of 1 ml/min. 
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Fig 5: UV spectrum of each peak in the chromatogram of DON glucuronide (DONGLU) 
synthesis reaction (Fig 4A). Only the peak, retention time 3.7 min, shows a similar UV 
spectrum to DON, which has a maximum absorbance close to 220 run. There is just one 
major peak from 190 to 300 nm for DON and DON glucuronide. Tentatively, the peak is 
DONGLU. 
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were collected and combined to further HPLC purification. (B) showed elution of a partial 
purified DON(extracted from F. g~aminea~um culture) by 10% methanol; each fraction 
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glucuronide (C, hydrolysis). YMC-PACK C18 column (10 cm X 4.6 mm, 5µm particle size) 
was used with a gradient of 6- 9% methanol (the rest is 0.1 % acetic acid water) over 40 
min, flow rate of 1 ml/min. 
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Fig 8: After Sephadex LH-20 fractionation, fraction number 23, 24 and 25 including 
DONGLU were combined and subjected to a analytical scale purification HPLC system. A 
reversal phase Atlantic dClg column (5 µm, 250 X 4.5 mm) fitted with an in-line filter was 
used to separate DONGLU and impurities. The retention time of DONGLU was 14.6 min 
(A), which was collected. The retention time of DON standard was 23.4 min (B). Mobile 
phase A was MQ water; mobile phase B was acetonitrile. The gradient was initially 0% B, 
linear to 12% B over 15 min, switching to 50%Bat 17 min, and holding at 50% A until 25 
min then returning to initial conditions at 30 min and holding 0% for 2 min. Total flow rate 
was a constant 0.9 ml/min. DON and DONGLU have a similar UV spectrum as seen in 
insert in chromatograms A + B, which have a maximum UV absorption close to 220 nm. 
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Fig 8 continued 
The structure of DON glucuronide was further identified by MS and NMR. The 
expected molecular weight for DON glucuronide is 470 g/mol. The [DON-3-GLU-H] - peak 
for DON glucuronide with m/z of 471 was clearly observed on both ESI negative ion and 
APCI negative ion because of loss of —H at the group -COON. APCI negative ion also 
shows m/z 471 peaks was fragmented to [DON-3-GLU-CH2O-H] - = 441 and [DON-3- 
DON-CH2O-O-H] = 425 as the main fractions. There are three-hydroxyl group at C-3, 7 
and 15 of DON. The 3-and 15-hydroxyl groups are readily acylated through chemical 
synthesis or biosynthesis, while -7 hydroxyl of DON is never found acylated in foods. At 
the same time, it is possible to distinguish DON-3-glucuronide from DON-15-glucuronide 
due to the loss of CH2O (-30) from the - CH2OH group attached to the C-6 position of the 
DON-3-glucuronide. The fraction 441 in APCI negative ion shows that the DON 
glucuronide synthesized was likely to be DON-3 glucuronide (Fig 9, 10). 
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NMR spectroscopy is extremely useful for determining the structure of molecules 
because the local environment around a given nucleus in a molecule will slightly perturb 
the local magnetic field exerted on that nucleus and affect its exact transition energy. 
Therefore, addition of glucuronic acid to the hydroxyl group of DON influences the 
chemical shift of the local carbon, whereas the chemical shift of other carbons won't be 
changed after addition of a glucuronide conjugate. Because the amount of DON and DON 
glucuronide (~1 mg) were limited in this NMR assay, several carbon signals at higher 
chemical shifts did not appear in the 13C-NMR spectra, such as C=O. At the same time, the 
carbon signals of D-methanol (solvent) overlapped the carbon signals of the sample. 
However, analysis of the NMR spectrum of the purified DON glucuronide compared to that 
of the parent compound, DON, confirmed successful synthesis of DON glucuronide and the 
placement of the glucuronide moiety at the expected 3-OH position of DON for the 
following reasons: comparative lH NMR DON and DON glucuronide showed two new 
double peaks (4.41 ppm and 3.73 ppm) and multiple peaks from 3.25-3.50 ppm 
corresponding to DON glucuronide NMR assignments (Fig 11). Comparative 13C NMR of 
DON and DON glucuronide showed new carbon peaks (103.4 ppm, 78.1 ppm, 75 ppm, 
73.9 ppm) that could be assigned to DON glucuronide. The carbon of -COOH from the 
glucuronide is expected at 172175 ppm (Fig 12). The same NMR spectrum for 
glucuronide moiety has been found in the glucuronide moiety of dobutamine 
monoglucuronides (Anna Alonen, 2005). At the same time, Savard (1991) reported that the 
only difference between DON-3-glucoside and DON-15-glucoside in chemical shifts of 
NMR was the carbon attached to glucose. This is in accordance with our finding that only a 
shift at carbon which carbon number 3 was expected for the carbon attached to glucuronide 
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moiety. A downfield chemical shift (b ppm) (to the left) of 5.9 ppm was observed for 
carbon 3 (DON 70, DON glucuronide 75.9) between the spectra of DON and putative DON 
glucuronide, whereas no shift at carbon 15 further indicated that the DON glucuronide 
synthesized in our experiment was DON-3- glucuronide (Fig 9). 
Extinction coefficient of DON glucuronide and DON standard were obtained through 
measuring the absorption at 220 nm of 10.6-106 µg DONGLU/ml and 10100 µg DON/ml 
(Fig 13). The sm of the extinction coefficients was calculated as 4715.7(L/cm/mol) for DON 
glucuronide (Fig 13A) and 6555.8 (L/cm/mol) for DON (Fig 13B). For spectrophotometric 
determination of type B trichochecenes, different values ranging from Em 4500 to 7040 for 
the molar absorption have been found in the literature, as a result, ~m = 6400 is used as the 
molar absorptivity for all type B trichochecenes in acetonitrile (Krska et al., 2001). Krsta et 
al. (2004) found DON has maximum UV absorption at 217 nm. The mean of the extinction 
coefficients was calculated as 6727 (L/cm/mol) for DON (Sigma) AND 6825 (L/cm/mol) 
for DON (Biopure). The calculation for DON extinction coefficients in our research 
matched the literature. 
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Fig 9: The chemical structure DON glucuronide (MW= 472 g/mol) 
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Fig 10: ESI (negative mode) mass spectrum and APCI (negative mode) mass spectrum of 
purified DON glucuronide (DONGLU). The expected molecular weight for DON 
glucuronide is 472 g/mol. The [M]- peak for DONGLU with m/z of 471 was clearly 
observed on ESI and APCI negative ion because of loss of —H in the —COON group. APCI 
negative ion also shows m/z 471 peaks was fragmented to [DONGLU-CH2O-H]-=441 and 
[DONGLU-CH2O-O-H] =425 as the main fractions. The fraction 441 in APCI negative ion 
suggested DON glucuronide synthesized was likely to be DON-3 glucuronide. 
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Fig 11: 1H-NMR of DON (top) and DON glucuronide (bottom) spectra were run on a 
Varian VXR-400 NMR spectrometer. Comparative 1H NMR of DON and DON 
glucuronide showed two new double peaks (4.41 ppm and 3.73 ppm) and multiple peaks 
from 3.25-3.50 ppm assigned to DON glucuronide. 
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Varian VXR-400 NMR spectrometer. Comparative 13C NMR of DON and DON 
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to DON glucuronide. 
80 
1.2 - 
~ 0.8 -
c 0 
N 0.6 -
v 
N 
a 0.4 - 
0.2 - 
0 
A 
y = 4715.7x 
R2 = 0.9883 
0 0.00005 0.0001 0.00015 0.0002 0.00025 
Conc (mol/L) 
2-
1.8 -
1.6 -
,-, 1.4 - 
= 1.2 -
0 
N 1 -N .-. 
~ 0.8 -
Q 
0.6 -
0.4 -
0.2 -
0  
B 
y = 6555.8x 
R2 = 0.9989 
0 0.00005 0.0001 0.00015 0.0002 0.00025 0.0003 
mol/L 
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Comparative immunotoxicity of DON and DON glucuronide 
Effect of cell number on absorbance at 490 nm measured using the CellTiter 96® 
Assay showed a linear response with correlation coefficient, r = 0.94 for K562 cells in 
cell numbers from 2000 to 128000 (Fig 14). At the same time, linear regression analysis 
revealed high correlation between OD signals and the seeded cell number from 1626 to 
26000 (r = 0.98) following 48h incubations (Fig 15). The numbers of cells seeded for 
MTS and trypan blue exclusion assays were 25000 cells per well/ 2O0µ1 because DON 
addition should inhibit cell viability. 
The cytotoxicity of DON and DON glucuronide were measured in a concentration 
range from 0.13 µM to 135 µM and from 1.1 µM to 270 µM, respectively and results 
shown in Fig 16 and Fig 17. A significant decrease in cell numbers compared with 
controls was observed with DON at concentrations greater than 148 ng/ml (0.5 µM), 
with ICSo of 389 ng/ml (1.31 µM) in MTS assay. As DON concentrations increased 
from 2.1 to 67.5 µM, inhibition of cell viability gradually increased with cell numbers 
from 32.5 to 18.1 %control. There was no significant difference in cell viability in DON 
concentrations between 67.5 and 13.5 µM (Fig 16). Viable cells were observed at all 
concentrations of DON and DON glucuronide tested, using trypan blue exclusion assay, 
even at highest concentration of DON, 135 µM. The live cells within each sample were 
converted to the percentage of live cells of the control, and plotted against the 
concentration to get dose-response curve (Fig 17). The ICSo values both as mass and 
molar concentrations for DON and DON glucuronide were 3 89 ng/ml (1.31 µM) and 
> 127 µg/ml (>270 µM) measured by MTS assay (Table 2). No significant cytotoxicity 
was observed with up to 270 µM DONGLU by MTS assay (Fig 16). At the same time, 
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the ICSo values both as mass and molar concentrations for DON and DON glucuronide 
were 257 ng/ml (0.87 µM) and >127 µg/ml (>270 µM) measured by trypan blue 
exclusion assay. Trypan blue exclusion assay showed DON glucuronide at 270 µM 
inhibited cell numbers with 72% cell growth. However, we could not decide whether or 
not significant different from controls because of only two separately experiments and 
duplicate wells for each experiment. ANOVA showed that there was a significant 
difference in immunotoxicity between DON and DON glucuronide (p <0.0001), with no 
significant difference between MTS and trypan blue exclusion assay (p = 0.83 5 8). The 
cell number and necrosis was determined microscopically (Fig 18). The control was 
taken as 0% cell death. There was no significant cell death observed at 270 µM 
DONGLU. There was 60% cell death and 85% cell death at 2.1 µM DON and 135 µM 
DON, respectively after 48 h exposure. Effects of DON and DON glucuronide 
exposure, singly or in combination on K562 cells proliferation were measured by MTS 
assay after 48 h incubation. DONGLU did not influence DON toxicity at low, medium 
and high concentration combinations (0.5 µM, 1.3 µM and 8.4 µM) of each compound 
(Fig 19). 
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Fig 14: Effect of cell number on absorbance at 490 nm measured using the CellTiter 96® 
Assay. Various numbers of K562 cells were added to the wells of 96-well plate in complete 
RPMI medium. After 90 min at 37°C in a humidified, 5% CO2 atmosphere, the absorbance 
at 490 nm was recorded (the background subtracted). Each point represents the mean ~ SD 
of 3 replicates. The correlation coefficient (r) of the line was 0.94 for K562 cells between 
2000 to 128000, indicating a linear response between cell number and absorbance at 490 
nm. 
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Cell number in wells (x100) 
Fig 15. Effect of cell number on absorbance at 490nm measured using the CellTiter 96® 
Aqueous One Solution Assay to decide the number of cells to be seeded. Different 
concentration cells in medium were added to 96 plates and incubated 48 h, and then 15 µl 
CellTiter was added. Each point represents the mean ~ SD of 3 replicates. The correlation 
coefficient of the line was 0.98, indicating a linear response between cell number from 1626 
to 26000 and absorbance at 490 nm after 48 h incubation. 25000 cells/200 µl well were 
seeded for the MTS assay and Trypan blue exclusion. 
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Fig16: Proliferation dose/response curve of K562 cells exposed to DON and DON 
glucuronide (DONGLU) measured by MTS assay. The values are expressed as percent 
of control (0µM DON/ DONGLU) and each value is a result of three separate 
experiments with three replicates/treatment. Bars represent standard errors of the means. 
* mean significant difference from control, p<0.01; * * mean significant difference from 
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Fig 17: Dose/response curve of K562 cells exposed on DON and DON glucuronide 
(DONGLU) measured by Trypan blue exclusion assay after 48 h incubation. The values are 
expressed as percent of control (0 µM) and each value is the mean of two separate 
experiments (duplicate each time). Trypan blue exclusion assay showed DON glucuronide 
at 270 µM inhibited cell proliferation with 72% cell growth. However, we could not decide 
whether or not significant different from controls because of only two separately 
experiments and duplicate wells for each experiment. 
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Table 2 ICso values for DON and DON Glucuronide (DONGLU) in K562 cells after 48 h 
incubation measured by MTS proliferation assay and trypan blue exclusion. DON ICso 
values were calculated from derived powder line. DONGLU ICso was higher than the 
maximum detected concentration (270 µM, Fig 15 and Fig 16). DONGLU has at least 200 
times less immunotoxicity than DON. Cell proliferation measured by Trypan blue 
exclusion or MTS were not statistically different. 
Sample name ng toxin/ml cell medium 
µM toxin/ml cell medium 
Trypan blue 
exclusion 
MTS assay 
Trypan blue 
exclusion 
MTS assay 
DON 257 389 ~ 98 0.87 1.31 ~ 0.33 
DONGLU > 127440 > 127440 >270 >270 
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Control 
DON 2.1 µM 
DON glucuronide 270 µM 
DON 135 µM 
Fig 18: Light microscopy (x100) of K562 cells exposed to 0µM DON, 270 µM DON 
glucuronide, 135 µM DON and 2.1 µM DON for 48 h. The numbers of K562 cells did not 
change after exposure to the maximum concentration of DON glucuronide. In contrast, the 
number of K562 cells were reduced after exposure to 2.1 µM DON and the maximum 
concentration of 135 µM DON with cell number as 40% of control and 15% of control, 
repectively. Note: cell debris at 135 µM DON. 
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Fig19: The relative proliferation of K562 cells exposed on DON, DON glucuronide 
(DONGLU), and DON and DONGLU combined in all concentrations (0.5 µM, 1.3 µM and 
8.4 µM). The values were expressed as percent of control (0 µM DON/DON glucuronide). 
This result is a mean of three separate experiments with triplicate wells per treatment. Bars 
represent standard errors of the mean. Letters denote significant differences, P<0.05. 
mean significantly different from control (P<0.05); * * mean significantly different from 
control (p<0.01). The result shows DONGLU did not influence DON toxicity at low, 
medium and high concentration combinations (0.5 µM, 1.3 µM and 8.4 µM) of each 
compound. 
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DISCUSSION 
This is the first study to synthesize DON glucuronide and compare the immunotoxicity 
of DON and DON glucuronide. Incubation of DON, UDPGA and rat liver microsomes led 
to glucuronidation of DON (Fig 4). The [DON-3-GLU-H] -peak for DON glucuronide 
with m/z of 471 was clearly observed on both ESI negative ion and APCI negative ion, in 
agreement with expected DON glucuronide molecular weight 472 g/mol. The fraction 441 
in APCI negative ion shows that the DON glucuronide synthesized was likely to be DON-3 
glucuronide because loss of CH2O (-30) from the - CH2OH group attached to the C-6 
position of the DON-3-glucuronide produces this fraction (Fig 10). Comparative 1H NMR 
DON and DON glucuronide showed two new double peaks (4.41 ppm and 3.73 ppm) and 
multiple peaks from 3.25-3.50 ppm corresponding to DON glucuronide NMR assignments 
(Fig 11). Comparative 13C NMR of DON and DON glucuronide showed new carbon peaks 
(103.4 ppm, 78.1 ppm, 75 ppm, 73.9 ppm) that could be assigned to DON glucuronide. A 
downfield chemical shift (8 ppm) (to the left) of 5.9 ppm was observed for carbon 3 (DON 
70, DON glucuronide 75.9) between the spectra of DON and putative DON glucuronide, 
whereas no shift at carbon 15 further indicated that the DON glucuronide synthesized in our 
experiment was DON-3- glucuronide (Fig 12). In accordance, Savard (1991) reported that 
the only difference between DON-3-glucoside and DON-15-glucoside in chemical shifts of 
NMR was the carbon attached to glucose. 
Studies in vitro and on animal models have determined that DON can be rapidly 
metabolized to DON glucuronide. Garesis et al. (1987) reported a total of 40.4% of the 
administered dose of DON was found to be conjugated with glucuronic acid (hepatic 
perfusate 20.4%, bile 19.2%, hepatocytes 0.8% of DON administered, respectively) when 
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an isolated rat liver was perfused with DON at a dose of 3 mg in a recirculating perfusion 
system. Sprague-Dawley rats received a single dose of [14C] DON (5.0 ~ 0.1 mg/kg body 
weight, 5.5 ~ 0.1 µCi/kg) and the distribution of DON in body fluids was investigated over 
72 h. A total of 37% of the administered DON was excreted in the urine and DON-
glucuronide was implicated as the major urinary metabolite based on reverse-phase HPLC 
analysis of ~3-glucuronidase and sulphatase-treated samples (Meky et al., 2003). Corn 
contaminated with DON was added to the diets of three dairy cows for 5 d. After incubating 
urine with (3-glucuronidase, the concentration of unconjugated DOM-1 increased by 7 to 
15-fold whereas unconjugated DON increased 1.6 to 3-fold (Cote et al., 1986). After 
administrating intravenous and oral doses (0.5 and 5.0 mg DON/kg, respectively) to sheep, 
the metabolic formation of the glucuronide conjugate after iv and oral administration of 
DON appeared to occur quite efficiently (iv, 21%; oral, 75%). The de-epoxide metabolite, 
DOM-1, accounted for only a minor portion of the dose after either dosing regimen (iv, less 
than 2.0%; oral, less than 0.3%), but DOM-1 occurred predominantly as the glucuronide 
conjugate (Prelusky et al., 1985). In lactating sheep, using a combination of radioisotopic 
counting and chromatographic detection techniques, the kinetics and metabolic fate of DON 
in plasma, urine and bile were studied, its major plasma metabolite, DON glucuronide, 
accounted for 13% of the plasma radioactivity levels (Prelusky et al., 1987). The pigs were 
fed a commercial diet with 3-acetyl DON added in a concentration of 2.5 mg/kg feed for 
2.5 days. A significant part of the DON in plasma was a glucuronide conjugate (42 ~ 7%) 
(Eriksen et al., 2003). Evidence shows DON could be biotransformed to DONGLU in 
human through comparing DON concentration in urine following ~3 -glucuronidase 
treatment. Urine samples were collected from female inhabitants of Linxian County, China, 
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a high-risk region for esophageal cancer (OC) and an area of potentially high DON 
exposure, and Gejiu, a low risk region in China. DON was detected in all 15 samples 
following ~3 -glucuronidase treatment with the increase in DON recovered following 
enzyme treatment ranging from 1.2-2.8-fold (Meky et al., 2003). Therefore, DON 
glucuronide has been found in urine or plasma in different animals and humans. The 
amounts of DON glucuronide in body fruits are range from 13% ~75%. In our study, the 
same concentration of DON and DON glucuronide combination were used to investigation 
of the interaction of both compounts. 
Our present research demonstrated that DON was metabolized to DON-3-glucuronide 
in vitro through incubation of DON, UDPGA and rat liver microsomes. MTS proliferation 
assay and trypan blue exclusion assay have determined that DON glucuronide was a 
detoxification product and had no toxicity at up to 270 µM. The —OH group at C3 could be 
one of reasons of DON toxicity. Some evidence has shown less toxicity in DON-related 
compounds without —OH groups at carbon 3. Sundstol Eriksen reported (2004) that 3-acetyl 
DON was less toxic than DON and 15-acetyl DON and 15-acetyl DON was equal in 
toxicity to DON in Swiss mouse 3T3 fibroblasts cells. Poppenberger (2003) reported that 
UDP-glucosyltransferase, which catalyzes the transfer of glucose from UDP-glucose to the 
hydroxyl group at carbon 3 of DON, is able to detoxify DON. Additionally, DON can be 
biotransformed to 3-keto-4-DON by some bacteria in soil, and the metabolite exhibited a 
remarkably decreased (to less than one tenth) immunosuppression evaluated by means of a 
bioassay based on the mitogen-induced and mitogen-free proliferations of mouse spleen 
lymphocytes (Shima et al., 1997). These results are in accordance with our finding that 
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chemical groups conjugated with carbon 3 hydroxyl of DON are DON detoxification 
routes. 
UDP-glucuronosyltransferases (UGTs) metabolize a wide range of endogenous and 
xenobiotic substrates, typically forming polar glucuronide conjugates. Glucuronidation is 
conventionally viewed as facilitating the toxicological deactivation and excretion of 
xenobiotics. DON glucuronide is very water soluble and more polar than DON. 
Comparative immunotoxicity in K562 cells proliferation assays determined that DON 
glucuronides had no toxicity at up to 270 µM. Lesser toxicity of xenobiotic glucuronides 
has been found in other cases. For example, resveratrol was cytotoxic at 30 µM, but no 
cytotoxicity was observed for its glucuronide metabolites at concentrations as high as 3 00 
µM (Wang et al., 2004). Comparing cytotoxicity effect of PhIP between CHO cells and 
repair-deficient CHO cell transfected with human UGT1A1 expressing SP3hUGT1A1, a 
form of UGT, Malfatti et al. (2005) showed that UDP-glucuronosyltransferase proteins 
(UGT 1 A 1) detoxified food-borne carcinogenicheterocyclic amines through catalyzing the 
glucuronidation of N-hydroxy-PhIP. Research in our lab showed that glucuronidation was a 
detoxification reaction in that daidzein and genistein glucuronides had lesser biological 
activity than isoflavone aglycones (Zhang et al., 2004). Therefore, phase II 
biotransformation, glucuronidation is a detoxified route for some xenobiotic substrates. 
In our research, K562 cells were used to a cell model to investigate immunotoxicity of 
DON and DON glucuronide. K562 cells, a human myeloid leukemia cell line, showed 
similar responses to DON as did human peripheral blood leukocytes but without exogenous 
mitogens. Other research showed that K562 cells are a human erythroleukemia continuous 
cell line with a lymphoblast-like morphology (Koeffler and Golde 1980), and K562 blasts 
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can differentiate into recognizable progenitors of the erythrocytic, granulocytic and 
monocytic series (Lozzio et al., 1981). K562 cells are easily cultured. Visconti et al. (1991) 
evaluated cytotoxicity of twenty-three Fusa~ium mycotoxins on human K-562 cells as well 
as their inhibitory effect on proliferation of phytohemagglutinin-stimulated human 
peripheral blood lymphocytes. The cytotoxicity of trichothecenes to this human cell line 
was similar to their inhibition of mitogen induced human lymphocyte blastogenesis with 
ICSo of 430 ng DON/ml. Our method also showed that K562 cells were sensitive to DON 
with an ICSo of 389 ng/ml in MTS assay. The MTS tetrazolium compound is bioreduced by 
cells into a colored formazan product that is soluble in tissue culture medium. This 
conversion is presumably accomplished by NADPH or NADH produced by dehydrogenase 
enzymes in metabolically active cells. Therefore the mechanism of the toxicity of DON 
appears to include decreased cellular metabolism and deceased/ inhibited cell proliferation. 
The viability of the cells was estimated by trypan blue exclusion method. When exposed to 
different concentrations of DON, the viability of the cells was depressed in a dose-
dependent manner, comparable to the result in MTS assay. 
Inhibition of cell proliferation by DON has been observed in different cell lines. DON 
effectively inhibited mitogen-induced lymphocyte proliferation with 50% inhibition at 216 
ng/ml (Meky et al., 2001). DON also inhibited macrophage cell proliferation at 50-1000 
ng/ml (Sugita-Konishi et al., 2001). Exposure to DON induces immature and mature B cells 
apoptosis and cytotoxicity after exposure at 100-1000ng/ml for 18h, with ECso at 500 ng/ml 
for apoptosis and 300 ng/ml for cytotoxicity, respectively. (Uzarski et al., 2003). The 
cytotoxicity of DON in porcine primary cultured hepatocytes showed the cell death of the 
hepatocytes at 10 µg/ml groups starting at 6 h after DON was added (Mikami et al., 2004). 
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DON concentrations in peripheral blood could be evaluated from DON toxicokinetics 
in animals and human epidemiology. DON was detected in human urine collected from the 
suspected high and low exposure regions in China by Meky et al. (2003). The mean levels 
of DON were 37 ng/ml (n = 11, range 14-94 ng/ml) and 12 ng/ml (n = 4, range 4-18 ng/ml) 
in high and low exposure regions correspond to daily exposure of 1.1-7.4 µg/kg/day and 
0.3-1.4 µg/kg/day respectively, following by (3- glucuronidase treatment. The true DON 
concentrations were much lower since the increase in parent DON following enzyme 
treatment ranged from 1.2 to 2.8-fold. Castrated male pigs (n = 11) were adapted to a diet 
containing DON (4.2 mg DON/kg) over a period of 7 days, the maximum DON serum 
concentration was 14 ng/ml (tm~ = 4.1 h) (Danicke et al., 2004). The maximal plasma 
concentrations of DON were 21.79 and 15.21 ng DON/ml after feeding castrated male pigs 
on naturally contaminated wheat (5.7 mg DON/kg) for 4-8 weeks (n = 5) or single doses (n 
= 6) (Goyarts and Danicke, 2005a). As a result, consuming naturally contaminated DON 
(4.2 - 5.7 mg DON/kg diet), the maximal plasma concentration of DON were 14 - 22 
ngDON/ml. Therefore, in most of cases, after chronic exposure to DON contaminated food 
(up to 5.7 mg DON/kg diet), the lower serum concentration (22 ng/ml) should have little 
physiological effects in inhibiting peripheral blood cell proliferation. 
On the other hand, doses of 50 to 500 ng/ml DON superinduced IL-2 mRNA 
expression in a dose and time-dependent manner (Li et al., 1997). Exposure of the murine 
macrophage cell line RAW 264.3 to 50 - 250 ng/ml DON for 24 markly enhanced the 
production of prostaglandin E2, a major COX-2 metabolite (Moon and Pestka, 2002). The 
LOAEL dose is 50 ng/ml for IL-2 and COX-2 gene expression dysfunction after DON 
exposure. 
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Therefore, determining the exposure concentrations of DON to cells is a crucial 
thing when cell culture bioassays are employed to study the immunotoxicity of DON. In 
our research, no significant cytotoxicity was observed for DON glucuronide at up to 270 
µM. DON glucuronide did not influence DON toxicity at low, medium and high 
concentration combinations (0.5µM, 1.3µM and 8.4µM) of each compound. These data 
show that DONGLUC is a detoxification product of DON. Immunoassay would probably 
have DON/DON glucuronide crossreactivity because the antibodies used are designed 
against 3, 7, 15 triacetyl-DON (Krska et al. 2001). Therefore, the immunoassay would not 
accurately indicate what amount of DON was present. DON glucuronide had no effect on 
DON toxicity when cell proliferation assay was used to screen DON exposure. As a result, 
measuring DON alone without DON glucuronide in human urine or plasma would be a 
suitable biomarker of DON exposure and toxicity. 
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